<SEC-DOCUMENT>0001140361-25-043261.txt : 20251125
<SEC-HEADER>0001140361-25-043261.hdr.sgml : 20251125
<ACCEPTANCE-DATETIME>20251125102435
ACCESSION NUMBER:		0001140361-25-043261
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		14
FILED AS OF DATE:		20251125
DATE AS OF CHANGE:		20251125

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TORONTO DOMINION BANK
		CENTRAL INDEX KEY:			0000947263
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				135640479
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283969
		FILM NUMBER:		251515851

	BUSINESS ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
		BUSINESS PHONE:		416-944-6367

	MAIL ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>ef20059873_424b2.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial; font-size: 9pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%P-%%-->
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right; font-weight: bold;">Filed Pursuant to Rule 424(b)(2)</div>
    <div>
      <div style="text-align: right; margin-bottom: 6pt; font-weight: bold;">Registration Statement No. 333-283969</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z90a0459bebd241fba634d235956acf84" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 3pt;"><img src="image00003.jpg"></div>
            </td>
            <td style="width: 90%; vertical-align: top;">
              <div style="text-align: center; font-size: 14pt; font-weight: bold;">The Toronto-Dominion Bank</div>
              <div style="text-align: center; font-size: 12pt; font-weight: bold;">$18,949,000</div>
              <div style="text-align: center; margin-top: 3pt; font-size: 10pt;">Digital Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>-Linked Notes due March 25, 2027</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="4" border="0" id="z9fce1f76d5c24dd0977af1cdc76ca2e9" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="background-color: rgb(0, 0, 0); vertical-align: top; width: 100%;" rowspan="1"><br>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 3pt;"><font style="font-weight: bold;">The notes do not bear interest.</font> The amount that you will be paid on your notes on the maturity date (March 25, 2027) is based on the performance of the
        Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> as measured from the pricing date (November 21, 2025)<font style="font-size: 8pt;">&#160;</font>to and including the valuation date (March 23, 2027). If the final level on the valuation date is greater than or equal to the
        threshold level of 85.00% of the initial level of 24,239.57, you will receive the threshold settlement amount of $1,121.50 for each $1,000 principal amount of your notes. If the final level on the valuation date is less than the threshold level of
        85.00% of the initial level, your payment, if any, will be less than the principal amount and you will have a loss equal to the percentage decrease below the threshold level times the downside multiplier of approximately 1.1765. <font style="font-weight: bold;">Specifically, if the final level declines by more than 15.00% from the initial level, you will lose approximately 1.1765% of the principal amount of your notes for every 1% that the final level has declined below the
          threshold level of 85.00% of the initial level. Despite the inclusion of the threshold level, due to the downside multiplier you may lose your entire principal amount.</font></div>
      <div style="text-align: justify; margin-top: 3pt;">To determine your payment at maturity, we will calculate the percentage change of the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, which is the percentage increase or decrease in the final level from the initial
        level. At maturity, for each $1,000 principal amount of your notes, you will receive an amount in cash, if anything, equal to:</div>
      <table cellspacing="0" cellpadding="0" id="z69405227d8f349f3b50c0b15a1e4e4f0" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 3pt;">

          <tr>
            <td style="width: 18pt; vertical-align: top;">&#9679;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>if the percentage change is greater than or equal to -15.00% (the final level is greater than or equal to 85.00% of the initial level), the threshold settlement amount; or</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z1ec7b808b0eb4a859ad18f32edc0b15f" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-top: 3pt;">

          <tr>
            <td style="width: 18pt; vertical-align: top;">&#9679;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>if the percentage change is negative and is below -15.00% (the final level is less than the initial level by more than 15.00%), the sum of (i) $1,000 plus (ii) the product of (a) $1,000 times (b) approximately 1.1765 times (c) the sum of
                the percentage change plus 15.00%. <font style="font-weight: bold;">You will receive less than the principal amount of your notes.</font></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 3pt; font-weight: bold;">The notes do not guarantee the return of principal at maturity.</div>
      <div style="text-align: justify; margin-top: 3pt;">The notes are unsecured and are not savings accounts or insured deposits of a bank. The notes are not insured or guaranteed by the Canada Deposit Insurance Corporation, the U.S. Federal Deposit
        Insurance Corporation or any other governmental agency or instrumentality. Any payments on the notes are subject to our credit risk. The notes will not be listed or displayed on any securities exchange or electronic communications network.</div>
      <div style="text-align: justify; margin-top: 3pt; font-weight: bold;">You should read the disclosure herein to better understand the terms and risks of your investment. See &#8220;Additional Risk Factors&#8221; beginning on page P-6 of this pricing supplement.</div>
      <div style="text-align: justify; margin-top: 3pt; font-weight: bold;">Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of these notes or determined that this pricing supplement, the
        product supplement, the underlier supplement or the prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</div>
      <div style="text-align: justify; margin-top: 3pt; margin-bottom: 6pt;"><font style="font-weight: bold;">The initial estimated value of the notes at the time the terms of your notes were set on the pricing date was $983.00 per $1,000 principal amount,
          which is less than the public offering price listed below.</font> See &#8220;Additional Information Regarding the Estimated Value of the Notes&#8221; on the following page and &#8220;Additional Risk Factors&#8221; beginning on page P-6 of this document for additional
        information. The actual value of your notes at any time will reflect many factors and cannot be predicted with accuracy.</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zf5dcafdeb370494fb0de4258bcfb1e5d" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 16%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">&#160;</td>
            <td style="width: 27.66%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; font-weight: bold;">Public Offering Price</div>
            </td>
            <td style="width: 27.66%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; font-weight: bold;">Underwriting Discount<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
            </td>
            <td style="width: 27.64%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; font-weight: bold;">Proceeds to TD<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
            </td>
          </tr>
          <tr>
            <td style="width: 16%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify;">Per Note</div>
            </td>
            <td style="width: 27.66%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div>$1,000.00</div>
            </td>
            <td style="width: 27.66%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div>$13.50</div>
            </td>
            <td style="width: 27.64%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div>$986.50</div>
            </td>
          </tr>
          <tr>
            <td style="width: 16%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify;">Total</div>
            </td>
            <td style="width: 27.66%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div>$18,949,000.00</div>
            </td>
            <td style="width: 27.66%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div>$255,811.50</div>
            </td>
            <td style="width: 27.64%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div>$18,693,188.50</div>
            </td>
          </tr>

      </table>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%;" id="z65b3d1f6840d46a7ab50fdcb972e7fe8" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: left; margin-top: 3pt; font-size: 8pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="margin-top: 3pt; font-size: 8pt;">See &#8220;Supplemental Plan of Distribution (Conflicts of Interest)&#8221; herein.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: right; font-size: 14pt;">TD Securities (USA) LLC</div>
      <div style="text-align: center; margin-top: 6pt;">Pricing Supplement dated November 21, 2025</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">The public offering price, underwriting discount and proceeds to TD listed above relate to the notes we issue initially. We may decide to sell additional notes after the date of
        this pricing supplement, at public offering prices and with underwriting discounts and proceeds to TD that differ from the amounts set forth above. The return (whether positive or negative) on your investment in the notes will depend in part on the
        public offering price you pay for such notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">We, TD Securities (USA) LLC (&#8220;TDS&#8221;) or any of our affiliates, may use this pricing supplement in the initial sale of the notes. In addition, we, TDS or any of our affiliates may
        use this pricing supplement in a market-making transaction in a note after its initial sale. <font style="font-weight: bold;">Unless we, TDS or any of our affiliates informs the purchaser otherwise in the confirmation of sale, this pricing
          supplement will be used in a market-making transaction.</font></div>
      <div style="text-align: justify; margin-bottom: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Information Regarding the Estimated Value of the Notes</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">The final terms for the Notes were determined on the Pricing Date, based on prevailing market conditions, and are set forth in this pricing supplement. The economic terms of the
        Notes are based on TD&#8217;s internal funding rate (which is TD&#8217;s internal borrowing rate based on variables such as market benchmarks and TD&#8217;s appetite for borrowing), and several factors, including any sales commissions expected to be paid to TDS, any
        selling concessions, discounts, commissions or fees expected to be allowed or paid to non-affiliated intermediaries, the estimated profit that TD or any of TD&#8217;s affiliates expect to earn in connection with structuring the Notes, the estimated cost
        TD may incur in hedging its obligations under the Notes and the estimated development and other costs which TD may incur in connection with the Notes. Because TD&#8217;s internal funding rate generally represents a discount from the levels at which TD&#8217;s
        benchmark debt securities trade in the secondary market, the use of an internal funding rate for the Notes rather than the levels at which TD&#8217;s benchmark debt securities trade in the secondary market is expected to have had an adverse effect on the
        economic terms of the Notes. On the cover page of this pricing supplement, TD has provided the initial estimated value for the Notes. The initial estimated value was determined by reference to TD&#8217;s internal pricing models which take into account a
        number of variables and are based on a number of assumptions, which may or may not materialize, typically including volatility, interest rates (forecasted, current and historical rates), price-sensitivity analysis, time to maturity of the Notes,
        and TD&#8217;s internal funding rate. For more information about the initial estimated value, see &#8220;Additional Risk Factors&#8221; herein. Because TD&#8217;s internal funding rate generally represents a discount from the levels at which TD&#8217;s benchmark debt securities
        trade in the secondary market, the use of an internal funding rate for the Notes rather than the levels at which TD&#8217;s benchmark debt securities trade in the secondary market is expected, assuming all other economic terms are held constant, to
        increase the estimated value of the Notes. For more information see the discussion under &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity &#8212; TD&#8217;s and TDS&#8217;s Estimated Value of the Notes Are Determined By Reference to TD&#8217;s
        Internal Funding Rates and Are Not Determined By Reference to Credit Spreads or the Borrowing Rate TD Would Pay for its Conventional Fixed-Rate Debt Securities&#8221;.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">TD&#8217;s estimated value on the Pricing Date is not a prediction of the price at which the Notes may trade in the secondary market, nor will it be the price at which TDS may buy or
        sell the Notes in the secondary market. Subject to normal market and funding conditions, TDS or another affiliate of TD&#8217;s intends to offer to purchase the Notes in the secondary market but it is not obligated to do so.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which TDS may initially buy or sell the Notes in the secondary market, if any, may exceed
        TD&#8217;s estimated value on the Pricing Date for a temporary period expected to be approximately 3 months after the Pricing Date because, in its discretion, TD may elect to effectively reimburse to investors a portion of the estimated cost of hedging
        its obligations under the Notes and other costs in connection with the Notes which TD will no longer expect to incur over the term of the Notes. TD made such discretionary election and determined this temporary reimbursement period on the basis of
        a number of factors, including the tenor of the Notes and any agreement TD may have with the distributors of the Notes. The amount of TD&#8217;s estimated costs which is effectively reimbursed to investors in this way may not be allocated ratably
        throughout the reimbursement period, and TD may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the Pricing Date of the Notes based on changes in market conditions and other factors that cannot be
        predicted.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">If a party other than TDS or its affiliates is buying or selling your Notes in the secondary market based on its own estimated value of your Notes which was calculated by
        reference to TD&#8217;s credit spreads or the borrowing rate TD would pay for its conventional fixed-rate debt securities (as opposed to TD&#8217;s internal funding rate), the price at which such party would buy or sell your Notes could be significantly less.</div>
      <div style="text-align: justify; font-size: 10pt; font-weight: bold;">We urge you to read the &#8220;Additional Risk Factors&#8221; in this pricing supplement.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Summary</div>
      <div style="text-align: justify; margin-bottom: 12pt; font-size: 10pt;">The information in this &#8220;Summary&#8221; section is qualified by the more detailed information set forth in this pricing supplement, the product supplement, the underlier supplement and
        the prospectus.</div>
      <table cellspacing="0" cellpadding="4" border="0" id="z9b1d3663fac143d79a7f5cafbb0d68d3" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Issuer:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">The Toronto-Dominion Bank (&#8220;TD&#8221;)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Issue:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Senior Debt Securities, Series H</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Type of Note:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Digital Notes (the &#8220;Notes&#8221;)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Term:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Approximately 16 months</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Reference Asset:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (Bloomberg Ticker: NDX)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">CUSIP / ISIN:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">89115L4L9 / US89115L4L90</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Agent:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">TD Securities (USA) LLC (&#8220;TDS&#8221;)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Currency:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">U.S. Dollars</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Minimum Investment:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">$1,000 and minimum denominations of $1,000 in excess thereof</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Principal Amount:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">$1,000 per Note; $18,949,000 in the aggregate for all the offered Notes; the aggregate Principal Amount of the offered Notes may be increased if TD, at its sole option,
                decides to sell an additional amount of the offered Notes on a date subsequent to the date of this pricing supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Pricing Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">November 21, 2025</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Issue Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">November 26, 2025</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Valuation Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">March 23, 2027, subject to postponement for market disruption events and other disruptions, as described under &#8220;General Terms of the Notes &#8212; Valuation Date(s)&#8221; in the
                product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Maturity Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">March 25, 2027, subject to postponement for market disruption events and other disruptions, as described under &#8220;General Terms of the Notes &#8212; Maturity Date&#8221; in the product
                supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Payment at Maturity:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">For each $1,000 Principal Amount of the Notes, we will pay you on the Maturity Date an amount in cash, if anything, equal to:</div>
              <div style="text-align: justify; text-indent: -18pt; margin-left: 36pt; margin-bottom: 6pt;"><font style="font-size: 10pt;">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 6pt;"> &#160; &#160; &#160; &#160; </font><font style="font-size: 10pt;">if the Final Level is <font style="font-style: italic;">greater than </font>or <font style="font-style: italic;">equal to </font>the Threshold Level, the Threshold Settlement Amount; or</font></div>
              <div style="text-align: justify; text-indent: -18pt; margin-left: 36pt; margin-bottom: 6pt;"><font style="font-size: 10pt;">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 6pt;">&#160; &#160; &#160; &#160; </font><font style="font-size: 10pt;">if the Final Level is <font style="font-style: italic;">less than</font> the Threshold Level, the <font style="font-style: italic;">sum</font> of (i) $1,000 <font style="font-style: italic;">plus</font> (ii)
                  the <font style="font-style: italic;">product</font> of (a) $1,000 <font style="font-style: italic;">times </font>(b) the Downside Multiplier <font style="font-style: italic;">times</font> (c) the <font style="font-style: italic;">sum</font>
                  of the Percentage Change <font style="font-style: italic;">plus</font> the Threshold Percentage.</font></div>
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">If the Final Level is less than the Threshold Level, investors will receive less than the Principal Amount of the Notes at maturity and may lose their
                entire Principal Amount.</div>
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">All amounts used in or resulting from any calculation relating to the Payment at Maturity will be rounded upward or downward, as appropriate, to the nearest cent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="font-size: 10pt; font-weight: bold;">Threshold Settlement<br>
                Amount:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">$1,121.50 per $1,000 Principal Amount of the Notes</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Threshold Percentage:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">15.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Threshold Level:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">20,603.6345, which is 85.00% of the Initial Level</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Downside Multiplier:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">The <font style="font-style: italic;">quotient</font> of the Initial Level <font style="font-style: italic;">divided by</font> the Threshold Level, which equals
                approximately 1.1765</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Percentage Change:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">The <font style="font-style: italic;">quotient</font> of (1) the Final Level <font style="font-style: italic;">minus</font> the Initial Level <font style="font-style: italic;">divided</font> by (2) the Initial Level, expressed as a percentage.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="font-size: 10pt; font-weight: bold;">Initial Level:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="font-size: 10pt; text-align: justify;">24,239.57, which was the Closing Level of the Reference Asset on the Pricing Date</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Final Level:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">The Closing Level of the Reference Asset on the Valuation Date, except in the limited circumstances described under &#8220;General Terms of the Notes &#8212; Market Disruption Events&#8221;
                and subject to adjustment as provided under &#8220;General Terms of the Notes &#8212; Unavailability of the Level of, or Change in Law Event Affecting, the Reference Asset; Modification to Method of Calculation&#8221; in the product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Closing Level:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">The Closing Level of the Reference Asset will be the closing level of the Reference Asset or any successor index (as defined in the product supplement) on any Trading Day
                for the Reference Asset, as displayed on Bloomberg Professional<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> service (&#8220;Bloomberg&#8221;) page &#8220;NDX &lt;INDEX&gt;&#8221; or any successor page on Bloomberg or any successor service, as applicable.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Trading Day:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">A day on which the Reference Asset is calculated and published by the Index Sponsor, regardless of whether one or more of the principal securities markets for the stocks
                included in the Reference Asset are closed on that day, if the Index Sponsor publishes the level of the Reference Asset on that day.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Business Day:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Any day that is a Monday, Tuesday, Wednesday, Thursday or Friday that is neither a legal holiday nor a day on which banking institutions are authorized or required by law
                to close in New York City.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">U.S. Tax Treatment:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">By purchasing a Note, each holder agrees, in the absence of a statutory or regulatory change or an administrative determination or judicial ruling to the contrary, to
                characterize the Notes, for U.S. federal income tax purposes, as prepaid derivative contracts with respect to the Reference Asset. Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank,
                Harris, Shriver &amp; Jacobson LLP, is of the opinion that it would be reasonable to treat the Notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Notes, it is
                possible that your Notes could alternatively be treated for tax purposes as a single contingent payment debt instrument, or pursuant to some other characterization, such that the timing and character of your income from the Notes could
                differ materially and adversely from the treatment described above. Please see the discussion below under &#8220;Material U.S. Federal Income Tax Consequences&#8221;.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Canadian Tax Treatment:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian Taxation&#8221; and in the product supplement under &#8220;Supplemental Discussion of Canadian Tax
                Consequences&#8221;, which applies to the Notes. We will not pay any additional amounts as a result of any withholding required by reason of the rules governing hybrid mismatch arrangements contained in section 18.4 of the Canadian Tax Act (as
                defined in the prospectus).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Calculation Agent:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div>TD <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Listing:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">The Notes will not be listed or displayed on any securities exchange or electronic communications network.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Clearance and Settlement:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">DTC global (including through its indirect participants Euroclear and Clearstream, Luxembourg) as described under &#8220;Description of the Debt Securities &#8212; Forms of the Debt
                Securities&#8221; and &#8220;Ownership, Book-Entry Procedures and Settlement&#8221; in the prospectus.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Canadian Bail-in:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">The Notes are not bail-inable debt securities (as defined in the prospectus) under the Canada Deposit Insurance Corporation Act.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top;">
              <div style="font-size: 10pt; font-weight: bold;">Change in Law Event:</div>
            </td>
            <td style="width: 77%; vertical-align: top;">
              <div style="font-size: 10pt; text-align: justify;">Not applicable, notwithstanding anything to the contrary in the product supplement.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Terms of Your Notes</div>
      <div style="text-align: justify; margin-bottom: 12pt; font-size: 10pt;">You should read this pricing supplement together with the prospectus, as supplemented by the product supplement and the underlier supplement, relating to our Senior Debt
        Securities, Series H, of which these Notes are a part. Capitalized terms used but not defined in this pricing supplement will have the meanings given to them in the product supplement. In the event of any conflict the following hierarchy will
        govern: first, this pricing supplement; second, the product supplement; third, the underlier supplement; and last, the prospectus. <font style="font-weight: bold; font-style: italic;">The Notes vary from the terms described in the product
          supplement in several important ways. You should read this pricing supplement carefully.</font></div>
      <div style="text-align: justify; margin-bottom: 12pt; font-size: 10pt;">This pricing supplement, together with the documents listed below, contains the terms of the Notes and supersedes all prior or contemporaneous oral statements as well as any
        other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should carefully consider, among other
        things, the matters set forth in &#8220;Additional Risk Factors&#8221; herein, &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplement and &#8220;Risk Factors&#8221; in the prospectus, as the Notes involve risks not associated with conventional debt
        securities. We urge you to consult your investment, legal, tax, accounting and other advisors concerning an investment in the Notes. You may access these documents on the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) website at www.sec.gov as
        follows (or if that address has changed, by reviewing our filings for the relevant date on the SEC website):</div>
      <table cellspacing="0" cellpadding="0" id="zd71f684a2e314a0db76870c7fd4bc9ab" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 10pt;">Prospectus dated February 26, 2025:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-left: 18pt; margin-bottom: 6pt; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm">http://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm</a></div>
      <table cellspacing="0" cellpadding="0" id="z52d5ade460524d3f8407898be8a261ce" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 10pt;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-size: 10pt;">Underlier Supplement dated February 26, 2025:</div>
            </td>
          </tr>

      </table>
      <div style="margin-left: 18pt; margin-bottom: 10pt; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm</a></div>
      <table cellspacing="0" cellpadding="0" id="z7f2e4e7a6b53403f9a3ef3e47f1171e9" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 10pt;">Product Supplement MLN-EI-1 dated February 26, 2025:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-left: 18pt; margin-bottom: 10pt; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm</a></div>
      <div style="text-align: justify; margin-bottom: 12pt; font-size: 10pt;">Our Central Index Key, or CIK, on the SEC website is 0000947263. As used in this pricing supplement, the &#8220;Bank,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; refers to The Toronto-Dominion Bank and its
        subsidiaries.</div>
      <div style="font-size: 10pt; text-align: justify;">We reserve the right to change the terms of, or reject any offer to purchase, the Notes prior to their issuance. In the event of any changes to the terms of the Notes, we will notify you and you will
        be asked to accept such changes in connection with your purchase. You may also choose to reject such changes, in which case we may reject your offer to purchase.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Risk Factors</div>
      <div style="text-align: justify; margin-bottom: 3pt; font-size: 10pt;">The Notes involve risks not associated with an investment in conventional debt securities. This section describes the most significant risks relating to the terms of the Notes.
        For additional information as to these risks, please see &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplement and &#8220;Risk Factors&#8221; in the prospectus.</div>
      <div style="text-align: justify; margin-bottom: 3pt; font-size: 10pt;">You should carefully consider whether the Notes are suited to your particular circumstances. Accordingly, investors should consult their investment, legal, tax, accounting and
        other advisors as to the risks entailed by an investment in the Notes and the suitability of the Notes in light of their particular circumstances.</div>
      <div style="text-align: center; margin-bottom: 3pt; font-size: 10pt; font-style: italic; font-weight: bold;">Risks Relating to Return Characteristics</div>
      <div style="margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">Principal at Risk.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">Investors in the Notes could lose their entire Principal Amount if there is a decline in the level of the Reference Asset by more than the Threshold Percentage. If the Final Level
        is less than the Initial Level by more than 15.00%, you will lose a portion of each $1,000 Principal Amount in an amount equal to the <font style="font-style: italic;">product </font>of (i) the Downside Multiplier <font style="font-style: italic;">times</font> (ii) the <font style="font-style: italic;">sum</font> of the negative Percentage Change <font style="font-style: italic;">plus</font> the Threshold Percentage <font style="font-style: italic;">times</font> (iii) $1,000.
        Specifically, you will lose approximately 1.1765% of the Principal Amount of each of your Notes for every 1% that the Final Level is less than the Initial Level in excess of the Threshold Percentage and you may lose your entire Principal Amount.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">The Notes Do Not Pay Interest and Your Return on the Notes May Be Less Than the Return on Conventional Debt Securities of Comparable Maturity.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">There will be no periodic interest payments on the Notes as there would be on a conventional fixed-rate or floating-rate debt security having the same term. The return that you
        will receive on the Notes, which could be negative, may be less than the return you could earn on other investments. Even if your return is positive, your return may be less than the return you would earn if you bought a conventional senior
        interest bearing debt security of TD.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">Your Potential Payment at Maturity on the Notes Is Fixed and Limited to the Threshold Settlement Amount and You Will Not Participate in Any Appreciation in the
        Level of the Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">Your potential Payment at Maturity on the Notes is fixed as of the Pricing Date and is limited to the Threshold Settlement Amount, which you will receive only if the Final Level
        is equal to or greater than the Threshold Level. The Notes do not provide for any participation in the positive performance of the Reference Asset no matter how much the level of the Reference Asset may rise above the Initial Level over the term of
        your Notes. Therefore, an investment in the Notes could result in a return, if any, that will be significantly less than that of a hypothetical direct investment in the Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">The Payment at Maturity Is Not Linked to the Level of the Reference Asset at Any Time Other than the Valuation Date.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">The Final Level will be the Closing Level of the Reference Asset on the Valuation Date (subject to adjustment as described elsewhere in this pricing supplement). Therefore, if the
        Closing Level of the Reference Asset dropped to a level that is less than the Threshold Level on the Valuation Date, you would not receive the Threshold Settlement Amount and would not receive your full Principal Amount and the Payment at Maturity
        for your Notes would be significantly less than it would have been had the Payment at Maturity been linked to the Closing Level of the Reference Asset prior to such drop in the level of the Reference Asset. Although the actual level of the
        Reference Asset on the Maturity Date or at other times during the term of your Notes may be higher than the Final Level, you will benefit from the Closing Level of the Reference Asset only on the Valuation Date.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">You Will Not Have Any Rights to the Reference Asset Constituents.</div>
      <div style="text-align: justify; font-size: 10pt;">As a holder of the Notes, your potential Payment at Maturity is limited to the Threshold Settlement Amount and you will not participate in any appreciation of the Reference Asset or Reference Asset
        Constituents. Additionally, you will not have voting rights or rights to receive cash dividends or other distributions or other rights that holders of the Reference Asset Constituents would have. The Final Level will not reflect any dividends paid
        on any Reference Asset Constituents.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">If You Purchase Your Notes at a Premium to Principal Amount, the Return on Your Investment Will Be Less Than the Return on Notes Purchased at Principal Amount
        and the Impact of Certain Key Terms of the Notes Will be Negatively Affected.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">The Payment at Maturity will not be adjusted based on the public offering price you pay for the Notes. If you purchase Notes at a price that differs from the Principal Amount of
        the Notes, then the return on your investment in such Notes held to the Maturity Date will differ from, and may be substantially less than, the return on Notes purchased at Principal Amount. If you purchase your Notes at a premium to Principal
        Amount and hold them to the Maturity Date, the return on your investment in the Notes will be less than it would have been had you purchased the Notes at Principal Amount or a discount to Principal Amount. In addition, the impact of the Threshold
        Level and the Threshold Settlement Amount on the return on your investment will depend upon the price you pay for your Notes relative to Principal Amount. For example, if you purchase your Notes at a premium to Principal Amount, the Threshold
        Settlement Amount will only permit a lower positive return on your investment in the Notes than would have been the case for Notes purchased at Principal Amount or a discount to Principal Amount. Similarly, the Threshold Level, while still
        providing some protection for the return on the Notes, will allow a greater percentage decrease in your investment in the Notes than would have been the case for Notes purchased at Principal Amount or a discount to Principal Amount.</div>
      <div style="text-align: center; margin-bottom: 5pt; font-size: 10pt; font-style: italic; font-weight: bold;">Risks Relating to Characteristics of the Reference Asset</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">There Are Market Risks Associated with the Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">The level of the Reference Asset can rise or fall sharply due to factors specific to the Reference Asset, the securities included in the Reference Asset (the &#8220;Reference Asset
        Constituents&#8221;) and their issuers (the &#8220;Reference Asset Constituent Issuers&#8221;), such as stock price volatility, earnings, financial conditions, corporate, industry and regulatory developments, management changes and decisions and other events, as
        well as general market factors, such as general market volatility and levels, interest rates and economic and political conditions. You, as an investor in the Notes, should make your own investigation into the Reference Asset, the Reference Asset
        Constituents and the Reference Asset Constituent Issuers. For additional information, see &#8220;Information Regarding the Reference Asset&#8221; herein.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">The Reference Asset Reflects Price Return, Not Total Return.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">The return on your Notes is based on the performance of the Reference Asset, which reflects the changes in the market prices of the Reference Asset Constituents. It is not,
        however, linked to a &#8220;total return&#8221; index or strategy, which, in addition to reflecting those price returns, would also reflect dividends paid on the Reference Asset Constituents. The return on your Notes will not include such a total return
        feature or dividend component.</div>
      <div style="text-align: center; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">As Compared to Other Underlier Sponsors, the Underlier Sponsor Retains Significant Control and Discretionary Decision-Making Over the Underlier, Which May Have
        an Adverse Effect on the Level of the Underlier and on Your Notes</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">Pursuant to the underlier methodology, the underlier sponsor retains the right, from time to time, to exercise reasonable discretion as it deems appropriate in order to ensure
        underlier integrity, including, but not limited to, changes to quantitative inclusion criteria. The underlier sponsor may also, due to special circumstances, apply discretionary adjustments to ensure and maintain quality of the underlier. Although
        it is unclear how and to what extent this discretion could or would be exercised, it is possible that it could be exercised by the underlier sponsor in a manner that materially and adversely affects the level of the underlier and therefore your
        notes. The underlier sponsor is not obligated to, and will not, take account of your interests in exercising the discretion described above.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">Your Notes Are Subject to Non-U.S. Securities Market Risk.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">The value of your Notes is linked to a Reference Asset that is comprised, in part, of stocks from one or more non-U.S. securities markets. An investment in Notes linked directly
        or indirectly to the value of securities issued by non-U.S. companies involves particular risks. Generally, non-U.S. securities markets may be more volatile than U.S. securities markets, and market developments may affect non-U.S. markets
        differently from U.S. securities markets. Direct or indirect government intervention to stabilize these non-U.S. markets, as well as cross shareholdings in non-U.S. companies, may affect trading prices and volumes in those markets. There is
        generally less publicly available information about non-U.S. companies than about those U.S. companies that are subject to the reporting requirements of the SEC, and non-U.S. companies are subject to accounting, auditing and financial reporting
        standards and requirements that differ from those applicable to U.S. reporting companies. Securities prices in non-U.S. countries are subject to political, economic, financial and social factors that may be unique to the particular country. These
        factors, which could negatively affect the non-U.S. securities markets, include the possibility of recent or future changes in the non-U.S. government&#8217;s economic and fiscal policies, the possible imposition of, or changes in, currency exchange laws
        or other non-U.S. laws or restrictions applicable to non-U.S. companies or investments in non-U.S. equity securities and the possibility of fluctuations in the rate of exchange between currencies. Moreover, certain aspects of a particular non-U.S.
        economy may differ favorably or unfavorably from the U.S. economy in important respects, such as growth of gross national product, rate of inflation, capital reinvestment, resources and self-sufficiency.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">We Have No Affiliation with the Index Sponsor and Will Not Be Responsible for Any Actions Taken by the Index Sponsor.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">Nasdaq, Inc. (the &#8220;Index Sponsor&#8221;)<font style="font-size: 8pt;">&#160;</font>is not an affiliate of ours and will not be involved in any offerings of the Notes in any way.
        Consequently, we have no control of any actions of the Index Sponsor, including any actions of the type that would require the Calculation Agent to adjust the Payment at Maturity. The Index Sponsor does not have any obligation of any sort with
        respect to the Notes. Thus, the Index Sponsor has no obligation to take your interests into consideration for any reason, including in taking any actions that might affect the value of, or any amount payable on, the Notes. None of our proceeds from
        any issuance of the Notes will be paid to the Index Sponsor, except to the extent that we are required to pay the Index Sponsor licensing fees with respect to the Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">Changes that Affect the Reference Asset May Adversely Affect the Market Value of, and Return on, the Notes.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">The policies of the Index Sponsor concerning the calculation of the Reference Asset, additions, deletions or substitutions of the Reference Asset Constituents and the manner in
        which changes affecting those Reference Asset Constituents, such as stock dividends, reorganizations or mergers, may be reflected in the Reference Asset and could adversely affect the market value of, and return on, the Notes. The market value of,
        and return on, the Notes could also be affected if the Index Sponsor changes these policies, for example, by changing the manner in which it calculates the Reference Asset, or if the Index Sponsor discontinues or suspends calculation or publication
        of the Reference Asset. If any such change occurs, the Calculation Agent may select a successor index or take other actions as discussed in the product supplement and, notwithstanding these adjustments, the market value of, and return on, the Notes
        may be adversely affected.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">Market Disruption Events and Postponements.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">The Valuation Date, and therefore the Maturity Date, are subject to postponement as described in the product supplement due to the occurrence of one or more market disruption
        events. For a description of what constitutes a market disruption event as well as the consequences of that market disruption event, see &#8220;General Terms of the Notes&#8212;Market Disruption Events&#8221; in the product supplement.</div>
      <div style="text-align: center; margin-bottom: 5pt; font-size: 10pt; font-style: italic; font-weight: bold;">Risks Relating to Estimated Value and Liquidity</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">TD&#8217;s Initial Estimated Value of the Notes at the Time of Pricing (When the Terms of Your Notes Were Set on the Pricing Date) is Less Than the Public Offering
        Price of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">TD&#8217;s initial estimated value of the Notes is only an estimate. TD&#8217;s initial estimated value of the Notes is less than the public offering price of the Notes. The difference
        between the public offering price of the Notes and TD&#8217;s initial estimated value reflects costs and expected profits associated with selling and structuring the Notes, as well as hedging its obligations under the Notes with a third party. Because
        hedging our obligations entails risks and may be influenced by market forces beyond our control, this hedging may result in a profit that is more or less than expected, or a loss.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">TD&#8217;s and TDS&#8217;s Estimated Value of the Notes Are Determined By Reference to TD&#8217;s Internal Funding Rates and Are Not Determined By Reference to Credit Spreads or
        the Borrowing Rate TD Would Pay for its Conventional Fixed-Rate Debt Securities.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">TD&#8217;s initial estimated value of the Notes and TDS&#8217;s estimated value of the Notes at any time are determined by reference to TD&#8217;s internal funding rate. The internal funding rate
        used in the determination of the estimated value of the Notes generally represents a discount from the credit spreads for TD&#8217;s conventional fixed-rate debt securities and the borrowing rate TD would pay for its conventional fixed-rate debt
        securities. This discount is based on, among other things, TD&#8217;s view of the funding value of the Notes as well as the higher issuance, operational and ongoing liability management costs of the Notes in comparison to those costs for TD&#8217;s
        conventional fixed-rate debt, as well as estimated financing costs of any hedge positions, taking into account regulatory and internal requirements. If the interest rate implied by the credit spreads for TD&#8217;s conventional fixed-rate debt
        securities, or the borrowing rate TD would pay for its conventional fixed-rate debt securities were to be used, TD would expect the economic terms of the Notes to be more favorable to you. Additionally, assuming all other economic terms are held
        constant, the use of an internal funding rate for the Notes is expected to increase the estimated value of the Notes at any time.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">TD&#8217;s Initial Estimated Value of the Notes Does Not Represent Future Values of the Notes and May Differ From Others&#8217; (Including TDS&#8217;s) Estimates.</div>
      <div style="text-align: justify; font-size: 10pt;">TD&#8217;s initial estimated value of the Notes was determined by reference to its internal pricing models when the terms of the Notes were set. These pricing models take into account a number of
        variables, such as TD&#8217;s internal funding rate on the Pricing Date, and are based on a number of assumptions as discussed further under &#8220;Additional Information Regarding the Estimated Value of the Notes&#8221; herein. Different pricing models and
        assumptions (including the pricing models and assumptions used by TDS) could provide valuations for the Notes that are different from, and perhaps materially less than, TD&#8217;s initial estimated value. Therefore, the price at which TDS would buy or
        sell your Notes (if TDS makes a market, which it is not obligated to do) may be materially less than TD&#8217;s initial estimated value. In addition, market conditions and other relevant factors in the future may change, and any assumptions may prove to
        be incorrect.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">The Estimated Value of the Notes Is Not a Prediction of the Prices at Which You May Sell Your Notes in the Secondary Market, If Any, and Such Secondary Market
        Prices, If Any, Will Likely Be Less Than the Public Offering Price of Your Notes and May Be Less Than the Estimated Value of Your Notes.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">The estimated value of the Notes is not a prediction of the prices at which TDS, other affiliates of ours or third parties may be willing to purchase the Notes from you in
        secondary market transactions (if they are willing to purchase, which they are not obligated to do). The price at which you may be able to sell your Notes in the secondary market at any time, if any, will be influenced by many factors that cannot
        be predicted, such as market conditions, and any bid and ask spread for similar sized trades, and may be substantially less than the estimated value of the Notes. Further, as secondary market prices of your Notes take into account the levels at
        which our debt securities trade in the secondary market, and do not take into account our various costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the Notes, secondary market
        prices of your Notes will likely be less than the public offering price of your Notes. As a result, the price at which TDS, other affiliates of ours or third parties may be willing to purchase the Notes from you in secondary market transactions, if
        any, will likely be less than the price you paid for your Notes, and any sale prior to the Maturity Date could result in a substantial loss to you.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">The Temporary Price at Which TDS May Initially Buy the Notes in the Secondary Market May Not Be Indicative of Future Prices of Your Notes.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which TDS may initially buy or sell the Notes in the secondary market (if TDS makes a
        market in the Notes, which it is not obligated to do) may exceed the estimated value of the Notes on the Pricing Date, as well as the secondary market value of the Notes, for a temporary period after the Pricing Date of the Notes, as discussed
        further under &#8220;Additional Information Regarding the Estimated Value of the Notes.&#8221; The price at which TDS may initially buy or sell the Notes in the secondary market may not be indicative of future prices of your Notes.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">The Market Value of Your Notes May Be Influenced by Many Unpredictable Factors.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">When we refer to the market value of your Notes, we mean the value that you could receive for your Notes if you chose to sell them in the open market before the Maturity Date. A
        number of factors, many of which are beyond our control, will influence the market value of your Notes, including:</div>
      <table cellspacing="0" cellpadding="0" id="z5b3b79c3596d49a19a4d0dede889d61e" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 5pt;">

          <tr>
            <td style="width: 4.5pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 10pt;">the level of the Reference Asset;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z7695bd36a533495eb30fb81b1284d912" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 5pt;">

          <tr>
            <td style="width: 4.5pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 10pt;">the volatility &#8211; i.e., the frequency and magnitude of changes &#8211; in the level of the Reference Asset;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z1bd1622992134fb7bd2e09d75f8538c3" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 5pt;">

          <tr>
            <td style="width: 4.5pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 10pt;">the dividend rates, if applicable, of the Reference Asset Constituents;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zadce6938601c4e978824ed1324b0e26b" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 5pt;">

          <tr>
            <td style="width: 4.5pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 10pt;">economic, financial, regulatory and political, military, public health or other events that may affect the prices of any of the Reference Asset Constituents and thus the level of the Reference Asset;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z5dc14f27d1d54be88981568020352924" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 5pt;">

          <tr>
            <td style="width: 4.5pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 10pt;">interest rates and yield rates in the market;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="ze300406dca324dfeb65c9b8bd96fbbfc" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 5pt;">

          <tr>
            <td style="width: 4.5pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 10pt;">the time remaining until your Notes mature;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="za9e303dd52de431a94412bc7f1a7bd02" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 5pt;">

          <tr>
            <td style="width: 4.5pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 10pt;">any fluctuations in the exchange rate between currencies in which the Reference Asset Constituents are quoted and traded and the U.S. dollar, as applicable; and</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z377e4333a1e8437db555ba99c0020c05" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 5pt;">

          <tr>
            <td style="width: 4.5pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 10pt;">our creditworthiness, whether actual or perceived, and including actual or anticipated upgrades or downgrades in our credit ratings or changes in other credit measures.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">These factors will influence the price you will receive if you sell your Notes before maturity, including the price you may receive for your Notes in any market-making
        transaction. If you sell your Notes prior to maturity, you may receive less than the Principal Amount of your Notes.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">The future levels of the Reference Asset cannot be predicted. The actual change in the level of the Reference Asset over the term of the Notes, as well as the Payment at Maturity,
        may bear little or no relation to the hypothetical historical closing levels of the Reference Asset or to the hypothetical examples shown elsewhere in this pricing supplement.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">There May Not Be an Active Trading Market for the Notes &#8212; Sales in the Secondary Market May Result in Significant Losses.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">There may be little or no secondary market for the Notes. The Notes will not be listed or displayed on any securities exchange or electronic communications network. TDS and our
        affiliates may make a market for the Notes; however, they are not required to do so. TDS and our affiliates may stop any market-making activities at any time. Even if a secondary market for the Notes develops, it may not provide significant
        liquidity or trade at prices advantageous to you. We expect that transaction costs in any secondary market would be high. As a result, the difference between bid and ask prices for your Notes in any secondary market could be substantial.</div>
      <div style="text-align: justify; font-size: 10pt;">If you sell your Notes before the Maturity Date, you may have to do so at a substantial discount from the public offering price irrespective of the level of the Reference Asset and, as a result, you
        may suffer substantial losses.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">If the Level of the Reference Asset Changes, the Market Value of Your Notes May Not Change in the Same Manner.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">Your Notes may trade quite differently from the performance of the Reference Asset. Changes in the level of the Reference Asset may not result in a comparable change in the market
        value of your Notes. Even if the level of the Reference Asset increases above the Initial Level during the term of the Notes, the market value of your Notes may not increase by the same amount and could decline.</div>
      <div style="text-align: center; margin-bottom: 5pt; font-size: 10pt; font-style: italic; font-weight: bold;">Risks Relating to Hedging Activities and Conflicts of Interest</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">The Agent Discount, if Any, Offering Expenses and Certain Hedging Costs Are Likely to Adversely Affect Secondary Market Prices.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">Assuming no changes in market conditions or any other relevant factors, the price, if any, at which you may be able to sell the Notes will likely be less than the public offering
        price. The public offering price includes, and any price quoted to you is likely to exclude, any underwriting discount paid in connection with the initial distribution, offering expenses as well as the cost of hedging our obligations under the
        Notes. In addition, any such price is also likely to reflect any dealer discounts, mark-ups and other transaction costs, such as a discount to account for costs associated with establishing or unwinding any related hedge transaction. In addition,
        if the dealer from which you purchase Notes, or one of its affiliates, is to conduct hedging activities for us in connection with the Notes, that dealer, or one of its affiliates, may profit in connection with such hedging activities and such
        profit, if any, will be in addition to any compensation that the dealer receives for the sale of the Notes to you. You should be aware that the potential for the dealer or one of its affiliates to earn fees in connection with hedging activities may
        create a further incentive for the dealer to sell the Notes to you in addition to any compensation they would receive for the sale of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">Trading and Business Activities by TD and Our Affiliates May Adversely Affect the Market Value of, and Any Amount Payable on, the Notes.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">TD and our affiliates may hedge our obligations under the Notes by purchasing securities, futures, options or other derivative instruments with returns linked or related to
        changes in the level of the Reference Asset or the prices of one or more Reference Asset Constituents, and we or they may adjust these hedges by, among other things, purchasing or selling any of the foregoing at any time. It is possible that we or
        one or more of our affiliates could receive substantial returns from these hedging activities while the market value of, and any amount payable on, the Notes declines. We or one or more of our affiliates may also issue or underwrite other
        securities or financial or derivative instruments with returns linked or related to the performance of the Reference Asset or one or more Reference Asset Constituents.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">These trading activities may present a conflict between the holders&#8217; interest in the Notes and the interests we and our affiliates will have in our or their proprietary accounts,
        in facilitating transactions, including options and other derivatives transactions, for our or their customers&#8217; accounts and in accounts under our or their management. These trading activities could be adverse to the interests of the holders of the
        Notes.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">We and our affiliates may, at present or in the future, engage in business with one or more Reference Asset Constituent Issuers, including making loans to or providing advisory
        services to those companies. These services could include investment banking and merger and acquisition advisory services. These business activities may present a conflict between us and our affiliates&#8217; obligations, and your interests as a holder
        of the Notes. Moreover, we and our affiliates may have published, and in the future expect to publish, research reports with respect to the Reference Asset or one or more Reference Asset Constituents. This research is modified from time to time
        without notice and may express opinions or provide recommendations that are inconsistent with purchasing or holding the Notes. Any of these business activities by us or one or more of our affiliates may affect the level of the Reference Asset or
        one or more Reference Asset Constituents and, therefore, the market value of, and any amount payable on, the Notes.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">There Are Potential Conflicts of Interest Between You and the Calculation Agent.</div>
      <div style="text-align: justify; font-size: 10pt;">The Calculation Agent will, among other things, determine the amount of your payment on the Notes. We will serve as the Calculation Agent and may appoint a different Calculation Agent after the Issue
        Date without notice to you. The Calculation Agent will exercise its judgment when performing its functions and may take into consideration our ability to unwind any related hedges. Because this discretion by the Calculation Agent may affect
        payments on the Notes, the Calculation Agent may have a conflict of interest if it needs to make any such decision. For example, the Calculation Agent may have to determine whether a market disruption event affecting the Reference Asset has
        occurred, and make certain adjustments if certain events occur, which may, in turn, depend on the Calculation Agent&#8217;s judgment whether the event has materially interfered with our ability or the ability of one of our affiliates to unwind our hedge
        positions. Because this determination by the Calculation Agent will affect the payment on the Notes, the Calculation Agent may have a conflict of interest if it needs to make a determination of this kind. For additional information as to the
        Calculation Agent&#8217;s role, see &#8220;General Terms of the Notes &#8212; Role of Calculation Agent&#8221; in the product supplement.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; margin-bottom: 5pt; font-size: 10pt; font-style: italic; font-weight: bold;">Risks Relating to General Credit Characteristics</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">Investors Are Subject to TD&#8217;s Credit Risk, and TD&#8217;s Credit Ratings and Credit Spreads May Adversely Affect the Market Value of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">Although the return on the Notes will depend on the Final Level of the Reference Asset, the payment of any amount due on the Notes is subject to TD&#8217;s credit risk. The Notes are
        TD&#8217;s unsecured debt obligations. Investors are dependent on TD&#8217;s ability to pay all amounts due on the Notes on the Maturity Date and, therefore, investors are subject to the credit risk of TD and to changes in the market&#8217;s view of TD&#8217;s
        creditworthiness. Any decrease in TD&#8217;s credit ratings or increase in the credit spreads charged by the market for taking TD&#8217;s credit risk is likely to adversely affect the market value of the Notes. If TD becomes unable to meet its financial
        obligations as they become due, investors may not receive any amounts due under the terms of the Notes.</div>
      <div style="text-align: center; margin-bottom: 5pt; font-size: 10pt; font-style: italic; font-weight: bold;">Risks Relating to Canadian and U.S. Federal Income Taxation</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">Significant Aspects of the Tax Treatment of the Notes Are Uncertain.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">Significant aspects of the U.S. tax treatment of the Notes are uncertain. You should consult your tax advisor about your tax situation and should read carefully the section
        entitled &#8220;Material U.S. Federal Income Tax Consequences&#8221; herein and in the product supplement.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">For a discussion of the Canadian federal income tax consequences of investing in the Notes, please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian
        Taxation&#8221; and in the product supplement under &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221; and the further discussion herein under &#8220;Summary&#8221;.</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt;">If you are not a Non-resident Holder (as that term is defined in the prospectus) for Canadian federal income tax purposes or if you acquire the Notes in the secondary market, you
        should consult your tax advisors as to the consequences of acquiring, holding and disposing of the Notes and receiving the payments that might be due under the Notes.</div>
      <div style="text-align: center; margin-bottom: 5pt; font-size: 10pt; font-style: italic; font-weight: bold;">General Risk Factors</div>
      <div style="text-align: justify; margin-bottom: 5pt; font-size: 10pt; font-weight: bold;">We May Sell an Additional Aggregate Principal Amount of the Notes at a Different Public Offering Price.</div>
      <div style="text-align: justify; font-size: 10pt;">At our sole option, we may decide to sell an additional aggregate Principal Amount of the Notes subsequent to the date of this pricing supplement. The public offering price of the Notes in the
        subsequent sale may differ substantially (higher or lower) from the original public offering price you paid as provided on the cover of this pricing supplement.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 5pt; color: rgb(0, 176, 80); font-size: 16pt;">Hypothetical Returns</div>
      <div style="text-align: justify; margin-top: 6pt; font-size: 10pt;">The examples and graph set out below are included for illustration purposes only. They should not be taken as an indication or prediction of future investment results and merely are
        intended to illustrate the impact that the various hypothetical levels of the Reference Asset on the Valuation Date could have on the Payment at Maturity assuming all other variables remain constant.</div>
      <div style="text-align: justify; margin-top: 6pt; font-size: 10pt;">The examples below are based on a range of Final Levels that are entirely hypothetical; the levels of the Reference Asset on any day throughout the term of the Notes, including the
        Final Level on the Valuation Date, cannot be predicted. The Reference Asset has been highly volatile in the past&#8212;meaning that the level of the Reference Asset has changed considerably in relatively short periods &#8212; and its performance cannot be
        predicted for any future period.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; font-size: 10pt;">The information in the following examples reflects hypothetical rates of return on the offered Notes assuming that they are purchased on the Issue Date at the
        Principal Amount and held to the Maturity Date. If you sell your Notes in a secondary market prior to the Maturity Date, your return will depend upon the market value of your Notes at the time of sale, which may be affected by a number of factors
        that are not reflected in the examples below, such as interest rates, the volatility of the Reference Asset and our creditworthiness. In addition, the estimated value of your Notes at the time the terms of your Notes were set on the Pricing Date is
        less than the original public offering price of your Notes. For more information on the estimated value of your Notes, see &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity &#8212; TD&#8217;s Initial Estimated Value of the Notes at the
        Time of Pricing (When the Terms of Your Notes Were Set on the Pricing Date) is Less Than the Public Offering Price of the Notes&#8221; in this pricing supplement. The information in the examples also reflect the key terms and assumptions in the box
        below.</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zb418d315ce0940eb97ae9b6c46bd7d26" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 38%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt; font-size: 10pt; font-weight: bold;">Key Terms and Assumptions</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); padding-bottom: 1px;">&#160;</td>
            <td style="width: 60%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 38%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt; font-size: 10pt;">Principal Amount</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 60%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="margin-top: 3pt; margin-bottom: 3pt; font-size: 10pt;">$1,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 38%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt; font-size: 10pt;">Threshold Settlement Amount</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 60%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="margin-top: 3pt; margin-bottom: 3pt; font-size: 10pt;">$1,121.50</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 38%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt; font-size: 10pt;">Threshold Level</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 60%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="margin-top: 3pt; margin-bottom: 3pt; font-size: 10pt;">85.00% of the Initial Level</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 38%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt; font-size: 10pt;">Downside Multiplier</div>
            </td>
            <td style="width: 1%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 60%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="margin-top: 3pt; margin-bottom: 3pt; font-size: 10pt;">Approximately 1.1765</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 38%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt; font-size: 10pt;">Threshold Percentage</div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 1px;">&#160;</td>
            <td style="width: 60%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="margin-top: 3pt; margin-bottom: 3pt; font-size: 10pt;">15.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0);">&#160;</td>
            <td style="vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt; font-size: 10pt;">Neither a market disruption event nor a non-Trading Day occurs on the originally scheduled Valuation Date</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0);">&#160;</td>
            <td style="vertical-align: top; border-right: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt; font-size: 10pt;">No change in or affecting any of the Reference Asset Constituents or the method by which the Index Sponsor calculates the Reference Asset</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
            <td style="vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="text-align: justify; margin-top: 3pt; margin-bottom: 3pt; font-size: 10pt;">Notes purchased on the Issue Date at the Principal Amount and held to the Maturity Date</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt; font-size: 10pt;">The actual performance of the Reference Asset over the term of your Notes, as well as the Payment at Maturity, if any, may bear little relation to the hypothetical examples shown
        below or to the historical levels of the Reference Asset shown elsewhere in this pricing supplement. For information about the historical levels of the Reference Asset during recent periods, see &#8220;Information Regarding the Reference Asset &#8212;
        Historical Information&#8221; below.</div>
      <div style="text-align: justify; margin-top: 6pt; font-size: 10pt;">Also, the hypothetical examples shown below do not take into account the effects of applicable taxes. Because of the U.S. tax treatment applicable to your Notes, tax liabilities
        could affect the after-tax rate of return on your Notes to a comparatively greater extent than the after-tax return on the Reference Asset Constituents.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; font-size: 10pt;">The levels in the left column of the table below represent hypothetical Final Levels and are expressed as percentages of the Initial Level. The amounts in the right column represent
        the hypothetical Payment at Maturity, based on the corresponding hypothetical Final Level, and are expressed as percentages of the Principal Amount of a Note (rounded to the nearest thousandth of a percent). Thus, a hypothetical Payment at Maturity
        of 100.000% means that the value of the cash payment that we would pay for each $1,000 of the outstanding Principal Amount of the offered Notes on the Maturity Date would equal 100.000% of the Principal Amount of a Note, based on the corresponding
        hypothetical Final Level and the assumptions noted above.</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z447a902dd8734b988051479b72d62ddd" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">Hypothetical Final Level</div>
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">(as Percentage of Initial Level)</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">Hypothetical Payment at Maturity</div>
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">(as Percentage of Principal Amount)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">150.000%</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">112.150%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">140.000%</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">112.150%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">130.000%</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">112.150%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">120.000%</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">112.150%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; background-color: #DBE5F1; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">112.150%</div>
            </td>
            <td style="width: 50%; vertical-align: top; background-color: #DBE5F1; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">112.150%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">112.000%</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">112.150%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">108.000%</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">112.150%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">104.000%</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">112.150%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">100.000%</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">&#160;112.150%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">90.000%</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">112.150%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; background-color: #DBE5F1; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">85.000%</div>
            </td>
            <td style="width: 50%; vertical-align: top; background-color: #DBE5F1; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">112.150%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">80.000%</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">94.118%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">70.000%</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">82.353%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">60.000%</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">70.588%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">50.000%</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">58.824%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">25.000%</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt;">29.412%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; background-color: #DBE5F1; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">0.000%</div>
            </td>
            <td style="width: 50%; vertical-align: top; background-color: #DBE5F1; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">0.000%</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt; font-size: 10pt;">If, for example, the Final Level were determined to be 25.000% of the Initial Level, the Payment at Maturity that we would pay on your Notes at maturity would be approximately
        29.412% of the Principal Amount of your Notes, as shown in the table above. As a result, if you purchased your Notes on the Issue Date at the Principal Amount and held them to the Maturity Date, you would lose approximately 70.588% of your
        investment (if you purchased your Notes at a premium to Principal Amount you would lose a correspondingly higher percentage of your investment). If the Final Level were determined to be 0.000% of the Initial Level, you would lose 100.000% of your
        investment in the Notes. In addition, if the Final Level were determined to be 140.000% of the Initial Level, the Payment at Maturity that we would pay on your Notes at maturity would be equal to 112.150% of each $1,000 Principal Amount of your
        Notes, as shown in the table above. As a result, if you held your Notes to the Maturity Date, your potential Payment at Maturity is limited to the Threshold Settlement Amount, regardless of the appreciation of the Reference Asset.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; font-size: 10pt;">The following examples illustrate the hypothetical Payment at Maturity for each Note based on hypothetical Final Levels of the Reference Asset, calculated based on the key terms and
        assumptions above. The values below have been rounded for ease of analysis.</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z3b04d8acb9684f35a7d190678e686ae5" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 12.94%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Example 1 &#8212;</div>
            </td>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Calculation of the Payment at Maturity where the Percentage Change is positive.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.94%; vertical-align: top;"><br>
            </td>
            <td style="width: 18%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Percentage Change:</div>
            </td>
            <td style="width: 69%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">5.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.94%; vertical-align: top;">&#160;</td>
            <td style="width: 18%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Payment at Maturity:</div>
            </td>
            <td style="width: 69%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt;">$1,121.50</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.94%; vertical-align: top;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: justify; margin-bottom: 10pt; font-size: 10pt;">On a $1,000 investment, a Percentage Change of 5.00% results in a Final Level that is greater than the Threshold Level; therefore, a holder of the Notes will receive the
                Threshold Settlement Amount, for a Payment at Maturity of $1,121.50, a return of 12.150% on the Notes.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.94%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Example 2 &#8212;</div>
            </td>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Calculation of the Payment at Maturity where the Percentage Change is positive.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.94%; vertical-align: top;">&#160;</td>
            <td style="width: 18%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Percentage Change:</div>
            </td>
            <td style="width: 69%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">30.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.94%; vertical-align: top;">&#160;</td>
            <td style="width: 18%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Payment at Maturity:</div>
            </td>
            <td style="width: 69%; vertical-align: top;">
              <div style="margin-bottom: 6pt; font-size: 10pt;">$1,121.50</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.94%; vertical-align: top;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: justify; margin-top: 6pt; margin-bottom: 10pt; font-size: 10pt;">On a $1,000 investment, a Percentage Change of 30.00% results in a Final Level that is greater than the Threshold Level; therefore, a holder of the Notes
                will receive the Threshold Settlement Amount, for a Payment at Maturity of $1,121.50, a return of 12.150% on the Notes.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.94%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Example 3 &#8212;</div>
            </td>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Calculation of the Payment at Maturity where the Percentage Change is negative (but the Final Level is greater than or equal to the Threshold Level).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.94%; vertical-align: top;">&#160;</td>
            <td style="width: 18%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Percentage Change:</div>
            </td>
            <td style="width: 69%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">-5.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.94%; vertical-align: top;">&#160;</td>
            <td style="width: 18%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Payment at Maturity:</div>
            </td>
            <td style="width: 69%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">$1,121.50</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.94%; vertical-align: top;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: justify; margin-bottom: 10pt; font-size: 10pt;">On a $1,000 investment, a Percentage Change of -5.00% results in a Final Level that is greater than the Threshold Level; therefore, a holder of the Notes will receive the
                Threshold Settlement Amount, for a Payment at Maturity of $1,121.50, a return of 12.150% on the Notes.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.94%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">Example 4 &#8212;</div>
            </td>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: justify; margin-bottom: 10pt; font-size: 10pt;">Calculation of the Payment at Maturity where the Percentage Change is negative (and the Final Level is less than the Threshold Level).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.94%; vertical-align: top;"><br>
            </td>
            <td style="width: 18%; vertical-align: top;">
              <div style="margin-bottom: 10pt; font-size: 10pt;">Percentage Change:</div>
            </td>
            <td style="width: 69%; vertical-align: top;">
              <div style="margin-bottom: 10pt; font-size: 10pt;">-60.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.94%; vertical-align: top;">&#160;</td>
            <td style="width: 18%; vertical-align: top;">
              <div style="margin-bottom: 10pt; font-size: 10pt;">Payment at Maturity:</div>
            </td>
            <td style="width: 69%; vertical-align: top;">
              <div style="margin-bottom: 10pt; font-size: 10pt;">$1,000 + [$1,000 &#215; approximately 1.1765 &#215; (-60.00% + 15.00%)]</div>
              <div style="margin-bottom: 10pt; font-size: 10pt;">= $1,000 &#8211; $529.41</div>
              <div style="margin-bottom: 10pt; font-size: 10pt;">= $470.59</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12.94%; vertical-align: top;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div style="font-size: 10pt; text-align: justify;">On a $1,000 investment, a Percentage Change of -60.00% results in a Final Level that is less than the Threshold Level; therefore, a holder of the Notes will receive a Payment at Maturity of
                $470.59, a return of -52.941% on the Notes.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; font-size: 10pt;">The following chart shows a graphical illustration of the hypothetical Payment at Maturity that we would pay on your Notes on the Maturity Date if the Final Level were any of the
        hypothetical levels shown on the horizontal axis. The hypothetical Payments at Maturity in the chart are expressed as percentages of the Principal Amount of your Notes and the hypothetical Final Levels are expressed as percentages of the Initial
        Level. The chart shows that any hypothetical Final Level of less than 85.000% (the section left of the 85.000% marker on the horizontal axis) would result in a hypothetical Payment at Maturity of less than 100.000% of the Principal Amount of your
        Notes (the section below the 100.000% marker on the vertical axis) and, accordingly, in a loss of principal to the holder of the Notes. The chart also shows that any hypothetical Final Level of greater than or equal to 85.000% (the section right of
        the 85.000% marker on the horizontal axis) would result in a fixed return on your investment.</div>
      <div style="text-align: center; margin-top: 6pt;"><img src="image00004.jpg"></div>
      <div style="text-align: justify; margin-top: 6pt; font-size: 10pt;">The Payments at Maturity shown above are entirely hypothetical; they are based on hypothetical levels of the Reference Asset that may not be achieved on the Valuation Date and
        assumptions that may prove to be erroneous. The actual market value of your Notes on the Maturity Date or at any other time, including any time you may wish to sell your Notes, may bear little relation to the hypothetical Payment at Maturity shown
        above, and these amounts should not be viewed as an indication of the financial return on an investment in the offered Notes. The hypothetical Payment at Maturity on the Notes in the examples above assume you purchased your Notes at their Principal
        Amount and have not been adjusted to reflect the actual public offering price you pay for your Notes. The return on your investment (whether positive or negative) in your Notes will be affected by the amount you pay for your Notes. If you purchase
        your Notes for a price other than the Principal Amount, the return on your investment will differ from, and may be significantly less than, the hypothetical returns suggested by the above examples. Please read &#8220;Additional Risk Factors &#8212; Risks
        Relating to Estimated Value and Liquidity &#8212; The Market Value of Your Notes May Be Influenced by Many Unpredictable Factors&#8221; in this pricing supplement.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; font-size: 10pt;">Payments on the Notes are economically equivalent to the amounts that would be paid on a combination of other instruments. For example, payments on the Notes are
        economically equivalent to a combination of a non-interest-bearing bond bought by the holder and one or more options entered into between the holder and us (with one or more implicit option premiums paid over time). The discussion in this paragraph
        does not modify or affect the terms of the Notes or the U.S. federal income tax treatment of the Notes, as described elsewhere in this pricing supplement.</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z5336e21565be4118a28ae413b0cce86b" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 1%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 98%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: justify; font-size: 10pt;"><font style="font-style: italic;">We cannot predict the actual Final Level or what the market value of your Notes will be on any particular Trading Day, nor can we predict the relationship
                  between the level</font>&#160;<font style="font-style: italic;">of the Reference Asset</font>&#160;<font style="font-style: italic;">and the market value of your Notes at any time prior to the Maturity Date. The actual amount that you will receive,
                  if any, at maturity and the rate of return on the offered Notes will depend on the actual Final Level, which will be determined by the Calculation Agent as described above. Moreover, the assumptions on which the hypothetical returns are
                  based may turn out to be inaccurate. Consequently, the amount of cash to be paid in respect of your Notes, if any, on the Maturity Date may be very different from the information reflected in the examples above.</font></div>
            </td>
            <td style="width: 1%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Information Regarding the Reference Asset</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">All disclosures contained in this document regarding the Reference Asset, including, without limitation, its make-up, method of calculation, and changes in any Reference Asset
        Constituents, have been derived from publicly available sources. We have not undertaken an independent review or due diligence of any publicly available information with respect to the Reference Asset. The information reflects the policies of, and
        is subject to change by, the Index Sponsor. The Index Sponsor, which owns the copyright and all other rights to the Reference Asset, has no obligation to continue to publish, and may discontinue publication of, the Reference Asset. None of the
        websites referenced in the Reference Asset description below, or any materials included in those websites, are incorporated by reference into this document or any document incorporated herein by reference.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">The graph below sets forth the information relating to the historical performance of the Reference Asset for the period specified. We obtained the information regarding the
        historical performance of the Reference Asset in the graph below from Bloomberg.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">We have not independently verified the accuracy or completeness of the information obtained from Bloomberg. The historical performance of the Reference Asset should not be taken
        as an indication of its future performance, and no assurance can be given as to the Final Level of the Reference Asset. We cannot give you any assurance that the performance of the Reference Asset will result in a positive return on your initial
        investment.</div>
      <div style="margin-bottom: 6pt; font-size: 10pt; font-weight: bold;">Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
      <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">We have derived all information regarding the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (&#8220;NDX&#8221;) contained in this document, including, without limitation, its make-up, method of calculation
        and changes in its components, from publicly available information. Such information reflects the policies of, and is subject to change by Nasdaq, Inc. and its affiliates (collectively, &#8220;Nasdaq&#8221;) (its &#8220;Index Sponsor&#8221; or &#8220;Nasdaq&#8221;).</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">NDX is published by Nasdaq, but Nasdaq has no obligation to continue to publish NDX, and may discontinue publication of NDX at any time. NDX is determined, comprised and
        calculated by Nasdaq without regard to this instrument.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;">As discussed more fully in the underlier supplement under the heading &#8220;Indices &#8211; Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>&#8221;, NDX includes 100 of the largest domestic and international
        non-financial securities listed on the Nasdaq Stock Market<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> based on market capitalization. NDX includes companies across major industry groups including computer hardware and software, telecommunications, retail and wholesale trade, and
        biotechnology, but does not contain securities of financial companies, including investment companies.</div>
      <div style="text-align: justify; font-size: 10pt;">NDX is calculated under a modified capitalization-weighted methodology. The methodology is expected to retain in general the economic attributes of capitalization-weighting while providing enhanced
        diversification. To accomplish this, Nasdaq will review the composition of NDX on a quarterly basis and adjust the weightings of components using a proprietary algorithm, if certain pre-established weight distribution requirements are not met.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-size: 10pt; font-weight: bold;">Historical Information</div>
      <div style="text-align: justify; margin-top: 6pt; font-size: 10pt;">The graph below shows the daily historical Closing Levels of the Reference Asset from November 21, 2015 through November 21, 2025. The dotted line represents the Threshold Level of
        20,603.6345, which is equal to 85.00% of the Closing Level of the Reference Asset on November 21, 2025.</div>
      <div style="text-align: center; margin-top: 6pt; font-size: 12pt; font-weight: bold;">Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (NDX)</div>
      <div style="text-align: center; margin-top: 6pt;"><img src="image00005.jpg"></div>
      <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-style: italic;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Material U.S. Federal Income Tax Consequences</div>
      <div style="text-align: justify; margin-bottom: 10pt; font-size: 10pt; font-weight: bold;">The U.S. federal income tax consequences of your investment in the Notes are uncertain. No statutory, regulatory, judicial or administrative authority directly
        discusses how the Notes should be treated for U.S. federal income tax purposes. Some of these tax consequences are summarized below, but we urge you to read the more detailed discussion under &#8220;Material U.S. Federal Income Tax Consequences&#8221; in the
        product supplement and discuss the tax consequences of your particular situation with your tax advisor. This discussion is based upon the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), final, temporary and proposed U.S. Department of
        the Treasury (the &#8220;Treasury&#8221;) regulations, rulings and decisions, in each case, as available and in effect as of the date hereof, all of which are subject to change, possibly with retroactive effect. Tax consequences under state, local and non-U.S.
        laws are not addressed herein. No ruling from the U.S. Internal Revenue Service (the &#8220;IRS&#8221;) has been sought as to the U.S. federal income tax consequences of your investment in the Notes, and the following discussion is not binding on the IRS.</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt; font-size: 10pt;"><font style="font-style: italic;">U.S. Tax Treatment.</font> Pursuant to the terms of the Notes, TD and you agree, in the absence of a statutory or regulatory
        change or an administrative determination or judicial ruling to the contrary, to characterize your Notes as prepaid derivative contracts with respect to the Reference Asset. If your Notes are so treated, you should generally recognize gain or loss
        upon the taxable disposition (including cash settlement) of your Notes in an amount equal to the difference between the amount you receive at such time and the amount you paid for your Notes. Such gain or loss should generally be long-term capital
        gain or loss if you have held your Notes for more than one year (otherwise such gain or loss should be short-term capital gain or loss if held for one year or less). The deductibility of capital losses is subject to limitations.</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt; font-size: 10pt; font-weight: bold;">Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris, Shriver &amp; Jacobson LLP, is
        of the opinion that it would be reasonable to treat your Notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Notes, it is possible that your Notes could alternatively be
        treated for tax purposes as a single contingent payment debt instrument, or pursuant to some other characterization, such that the timing and character of your income from the Notes could differ materially and adversely from the treatment described
        above, as described further under &#8220;Material U.S. Federal Income Tax Consequences &#8212; Alternative Treatments&#8221; in the product supplement.</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt; font-size: 10pt;">Except to the extent otherwise required by law, TD intends to treat your Notes for U.S. federal income tax purposes in accordance with the treatment described
        above and under &#8220;Material U.S. Federal Income Tax Consequences&#8221; of the product supplement, unless and until such time as the Treasury and the IRS determine that some other treatment is more appropriate.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-size: 10pt;"><font style="font-style: italic;">Section 1297</font>. We will not attempt to ascertain whether any Reference Asset Constituent Issuer would be treated as a passive foreign
        investment company (&#8220;PFIC&#8221;) within the meaning of Section 1297 of the Code. If any such entity were so treated, certain adverse U.S. federal income tax consequences might apply upon the taxable disposition of a Note. U.S. holders should refer to
        information filed with the SEC or the equivalent governmental authority by such entities and consult their tax advisors regarding the possible consequences to them if any such entity is or becomes a PFIC.</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt; font-size: 10pt;"><font style="font-style: italic;">Notice 2008-2. </font>In 2007, the IRS released a notice that may affect the taxation of holders of the Notes. According to
        Notice 2008-2, the IRS and the Treasury are considering whether a holder of an instrument such as the Notes should be required to accrue ordinary income on a current basis. It is not possible to determine what guidance they will ultimately issue,
        if any. It is possible, however, that under such guidance, holders of the Notes will ultimately be required to accrue income currently and this could be applied on a retroactive basis. According to the Notice, the IRS and the Treasury are also
        considering other relevant issues, including whether additional gain or loss from such instruments should be treated as ordinary or capital, whether non-U.S. holders of such instruments should be subject to withholding tax on any deemed income
        accruals, and whether the special &#8220;constructive ownership rules&#8221; of Section 1260 of the Code should be applied to such instruments. Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the significance, and the
        potential impact, of the above considerations on their investments in the Notes.</div>
      <div style="text-align: justify; margin-top: 10pt; font-size: 10pt;"><font style="font-style: italic;">Medicare Tax on Net Investment Income.</font> U.S. holders that are individuals, estates or certain trusts are subject to an additional 3.8% tax on
        all or a portion of their &#8220;net investment income,&#8221; or &#8220;undistributed net investment income&#8221; in the case of an estate or trust, which may include any income or gain realized with respect to the Notes, to the extent of their net investment income or
        undistributed net investment income (as the case may be) that when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a joint return (or a surviving spouse),
        $125,000 for a married individual filing a separate return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than the regular income tax. U.S. holders
        should consult their tax advisors as to the consequences of the 3.8% Medicare tax.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt; font-size: 10pt;"><font style="font-style: italic;">Specified Foreign Financial Assets. </font>U.S. holders may be subject to reporting obligations with respect to their Notes
        if they do not hold their Notes in an account maintained by a financial institution and the aggregate value of their Notes and certain other &#8220;specified foreign financial assets&#8221; (applying certain attribution rules) exceeds an applicable threshold.
        Significant penalties can apply if a U.S. holder is required to disclose its Notes and fails to do so.</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt; font-size: 10pt;"><font style="font-style: italic;">Backup Withholding and Information Reporting.</font> The proceeds received from a taxable disposition of the Notes will be
        subject to information reporting unless you are an &#8220;exempt recipient&#8221; and may also be subject to backup withholding at the rate specified in the Code if you fail to provide certain identifying information (such as an accurate taxpayer number, if
        you are a U.S. holder) or meet certain other conditions.</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt; font-size: 10pt;"><font style="font-style: italic;">Non-U.S. Holders.</font> If you are a non-U.S. holder, subject to Section 871(m) of the Code and FATCA, as discussed below,
        you should generally not be subject to U.S. withholding tax with respect to payments on your Notes or to generally applicable information reporting and backup withholding requirements with respect to payments on your Notes if you comply with
        certain certification and identification requirements as to your non-U.S. status including providing us (and/or the applicable withholding agent) a properly executed and fully completed applicable IRS Form W-8. Subject to Section 897 of the Code
        and Section 871(m) of the Code, as discussed below, gain realized from the taxable disposition of the Notes generally should not be subject to U.S. tax unless (i) such gain is effectively connected with a trade or business conducted by you in the
        U.S., (ii) you are a non-resident alien individual and are present in the U.S. for 183 days or more during the taxable year of such taxable disposition and certain other conditions are satisfied or (iii) you have certain other present or former
        connections with the U.S.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 8pt; font-size: 10pt;"><font style="font-style: italic;">Section 897.</font> We will not attempt to ascertain whether any Reference Asset Constituent Issuer would be treated as a
        &#8220;United States real property holding corporation&#8221; (a &#8220;USRPHC&#8221;) within the meaning of Section 897 of the Code. We also have not attempted to determine whether the Notes should be treated as &#8220;United States real property interests&#8221; (&#8220;USRPI&#8221;) as
        defined in Section 897 of the Code. If any such entity and the Notes were so treated, certain adverse U.S. federal income tax consequences could possibly apply, including subjecting any gain to a non-U.S. holder in respect of a Note upon a taxable
        disposition of the Note to U.S. federal income tax on a net basis, and the proceeds from such a taxable disposition to a 15% withholding tax. Non-U.S. holders should consult their tax advisors regarding the potential treatment of any such entity as
        a USRPHC and the Notes as USRPI.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 8pt; font-size: 10pt;"><font style="font-style: italic;">Section 871(m). </font>A 30% withholding tax (which may be reduced by an applicable income tax treaty) is imposed under Section
        871(m) of the Code on certain &#8220;dividend equivalents&#8221; paid or deemed paid to a non-U.S. holder with respect to a &#8220;specified equity-linked instrument&#8221; that references one or more dividend-paying U.S. equity securities or indices containing U.S.
        equity securities. The withholding tax can apply even if the instrument does not provide for payments that reference dividends. Treasury regulations provide that the withholding tax applies to all dividend equivalents paid or deemed paid on
        specified equity-linked instruments that have a delta of one (&#8220;delta-one specified equity-linked instruments&#8221;) issued after 2016 and to all dividend equivalents paid or deemed paid on all other specified equity-linked instruments issued after 2017.
        However, the IRS has issued guidance that states that the Treasury and the IRS intend to amend the effective dates of the Treasury regulations to provide that withholding on dividend equivalents paid or deemed paid will not apply to specified
        equity-linked instruments that are not delta-one specified equity-linked instruments and are issued before January 1, 2027.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 8pt; font-size: 10pt;">Based on the nature of the Reference Asset and our determination that the Notes are not &#8220;delta-one&#8221; with respect to the Reference Asset or any U.S. Reference
        Asset Constituent, our special U.S. tax counsel is of the opinion that the Notes should not be delta-one specified equity-linked instruments and thus should not be subject to withholding on dividend equivalents. Our determination is not binding on
        the IRS, and the IRS may disagree with this determination. Furthermore, the application of Section 871(m) of the Code will depend on our determinations on the date the terms of the Notes are set. If withholding is required, we will not make
        payments of any additional amounts.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 8pt; font-size: 10pt;">Nevertheless, after the date the terms are set, it is possible that your Notes could be deemed to be reissued for tax purposes upon the occurrence of certain
        events affecting the Reference Asset, any Reference Asset Constituent or your Notes, and following such occurrence your Notes could be treated as delta-one specified equity-linked instruments that are subject to withholding on dividend equivalents.
        It is also possible that withholding tax or other tax under Section 871(m) of the Code could apply to the Notes under these rules if you enter, or have entered, into certain other transactions in respect of the Reference Asset, any Reference Asset
        Constituent or the Notes. If you enter, or have entered, into other transactions in respect of the Reference Asset, any Reference Asset Constituent or the Notes, you should consult your tax advisor regarding the application of Section 871(m) of the
        Code to your Notes in the context of your other transactions.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 8pt; font-size: 10pt; font-weight: bold;">Because of the uncertainty regarding the application of the 30% withholding tax on dividend equivalents to the Notes, you are urged to consult
        your tax advisor regarding the potential application of Section 871(m) of the Code and the 30% withholding tax to an investment in the Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-size: 10pt;">As discussed above, alternative characterizations of the Notes for U.S. federal income tax purposes are possible. Should an alternative characterization of the Notes cause payments
        with respect to the Notes to become subject to withholding tax,</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-19</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 8pt; font-size: 10pt;">we (or the applicable withholding agent) will withhold tax at the applicable statutory rate and we will not make payments of any additional amounts.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 8pt; font-size: 10pt;"><font style="font-style: italic;">U.S. Federal Estate Tax Treatment of Non-U.S. Holders.</font> A Note may be subject to U.S. federal estate tax if an individual
        non-U.S. holder holds the Note at the time of his or her death. The gross estate of a non-U.S. holder domiciled outside the U.S. includes only property situated in the U.S. Individual non-U.S. holders should consult their tax advisors regarding the
        U.S. federal estate tax consequences of holding the Notes at death.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 8pt; font-size: 10pt;"><font style="font-style: italic;">Foreign Account Tax Compliance Act. </font>The Foreign Account Tax Compliance Act (&#8220;FATCA&#8221;) was enacted on March 18, 2010, and
        imposes a 30% U.S. withholding tax on &#8220;withholdable payments&#8221; (i.e., certain U.S.-source payments, including interest (and original issue discount), dividends, other fixed or determinable annual or periodical income, and the gross proceeds from a
        disposition of property of a type that can produce U.S.-source interest or dividends) and &#8220;passthru payments&#8221; (i.e., certain payments attributable to withholdable payments) made to certain foreign financial institutions (and certain of their
        affiliates) unless the payee foreign financial institution agrees (or is required), among other things, to disclose the identity of any U.S. individual with an account at the institution (or the relevant affiliate) and to annually report certain
        information about such account. FATCA also requires withholding agents making withholdable payments to certain foreign entities that do not disclose the name, address, and taxpayer identification number of any substantial U.S. owners (or do not
        certify that they do not have any substantial U.S. owners) to withhold tax at a rate of 30%. Under certain circumstances, a holder may be eligible for refunds or credits of such taxes.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 8pt; font-size: 10pt;">Pursuant to final and temporary Treasury regulations and other IRS guidance, the withholding and reporting requirements under FATCA will generally apply to
        certain &#8220;withholdable payments&#8221;, will not apply to gross proceeds on a sale or disposition, and will apply to certain foreign passthru payments only to the extent that such payments are made after the date that is two years after final regulations
        defining the term &#8220;foreign passthru payment&#8221; are published. If withholding is required, we (or the applicable paying agent) will not be required to pay additional amounts with respect to the amounts so withheld. Foreign financial institutions and
        non-financial foreign entities located in jurisdictions that have an intergovernmental agreement with the U.S. governing FATCA may be subject to different rules.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 8pt; font-size: 10pt;">Investors should consult their tax advisors about the application of FATCA, in particular if they may be classified as financial institutions (or if they hold
        their Notes through a foreign entity) under the FATCA rules.</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt; font-size: 10pt;"><font style="font-style: italic;">Proposed Legislation</font>. In 2007, legislation was introduced in Congress that, if it had been enacted, would have required
        holders of Notes purchased after the bill was enacted to accrue interest income over the term of the Notes despite the fact that there will be no interest payments over the term of the Notes.</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt; font-size: 10pt;">Furthermore, in 2013, the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been
        enacted, the effect of this legislation generally would have been to require instruments such as the Notes to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.</div>
      <div style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt; font-size: 10pt;">It is impossible to predict whether any similar or identical bills will be enacted in the future, or whether any such bill would affect the tax treatment of
        your Notes. You are urged to consult your tax advisor regarding the possible changes in law and their possible impact on the tax treatment of your Notes.</div>
      <div style="text-align: justify; font-size: 10pt; font-weight: bold;">Both U.S. and non-U.S. holders are urged to consult their tax advisors regarding the U.S. federal income tax consequences of an investment in the Notes, as well as any tax
        consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction (including that of TD and those of the Reference Asset Constituent Issuers).</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-20</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 8pt; color: rgb(0, 176, 80); font-size: 16pt;">Supplemental Plan of Distribution (Conflicts of Interest)</div>
      <div style="text-align: justify; margin-top: 9pt; font-size: 10pt;">We have appointed TDS, an affiliate of TD, as the agent for the sale of the Notes. Pursuant to the terms of a distribution agreement, TDS will purchase the Notes from TD at the
        public offering price less any underwriting discount set forth on the cover page of this pricing supplement for distribution to other registered broker-dealers.</div>
      <div style="text-align: justify; margin-top: 9pt; font-size: 10pt;">We or one of our affiliates will also pay a fee to iCapital Markets LLC, a broker-dealer in which an affiliate of Goldman Sachs &amp; Co. LLC, who is acting as a dealer in connection
        with the distribution of the Notes,<font style="font-size: 8pt;">&#160;</font>holds an indirect minority equity interest, for services it is providing in connection with this offering. TD will reimburse TDS for certain expenses in connection with its
        role in the offer and sale of the Notes, and TD will pay TDS a fee in connection with its role in the offer and sale of the Notes.</div>
      <div style="text-align: justify; margin-top: 9pt; font-size: 10pt;">Delivery of the Notes will be made against payment for the Notes on the Issue Date, which is the third (3rd) Business Day following the Pricing Date (this settlement cycle being
        referred to as &#8220;T+3&#8221;). Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in one Business Day (&#8220;T+1&#8221;), unless the parties to any such trade expressly agree
        otherwise. Accordingly, purchasers who wish to trade the Notes more than one Business Day prior to the Issue Date will be required to specify alternative settlement arrangements to prevent a failed settlement.</div>
      <div style="text-align: justify; margin-top: 9pt; font-size: 10pt;"><font style="font-style: italic;">Conflicts of Interest.</font> TDS is an affiliate of TD and, as such, has a &#8220;conflict of interest&#8221; in this offering within the meaning of Financial
        Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;) Rule 5121. In addition, TD will receive the net proceeds from the initial public offering of the Notes, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121.
        Consequently, the offering is being conducted in compliance with the provisions of FINRA Rule 5121. TDS is not permitted to sell Notes in this offering to an account over which it exercises discretionary authority without the prior specific written
        approval of the account holder.</div>
      <div style="text-align: justify; margin-top: 9pt; font-size: 10pt;">We, TDS or any of our affiliates may use this pricing supplement in the initial sale of the Notes. In addition, we, TDS or any of our affiliates may use this pricing supplement in a
        market-making transaction in a Note after its initial sale. <font style="font-weight: bold; font-style: italic;">If a purchaser buys the Notes from us, TDS or any of our affiliates, this pricing supplement is being used in a market-making
          transaction unless we, TDS or any of our affiliates informs such purchaser otherwise in the confirmation of sale.</font></div>
      <div style="text-align: justify; margin-top: 9pt; font-size: 10pt; font-weight: bold;">Prohibition on Sales to EEA Retail Investors</div>
      <div style="text-align: justify; margin-top: 9pt; font-size: 10pt;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European
        Economic Area (the &#8220;EEA&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, &#8220;MiFID II&#8221;); (ii) a customer within the
        meaning of Directive (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129, as amended.
        Consequently no key information document required by Regulation (EU) No 1286/2014 (the &#8220;EU PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore
        offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the EU PRIIPs Regulation.</div>
      <div style="text-align: justify; margin-top: 9pt; font-size: 10pt; font-weight: bold;">Prohibition on Sales to United Kingdom Retail Investors</div>
      <div style="text-align: justify; margin-top: 9pt; font-size: 10pt;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom
        (&#8220;UK&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union
        (Withdrawal) Act 2018 (the &#8220;EUWA&#8221;); or (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the &#8220;FSMA&#8221;) and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that
        customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently no key information document required by Regulation (EU)
        No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the &#8220;UK PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling
        the Notes or otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">P-21</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 10pt; color: rgb(0, 176, 80); font-size: 16pt;">Validity of the Notes</div>
      <div style="text-align: justify; margin-bottom: 10pt; font-size: 10pt;">In the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP, as special products counsel to TD, when the Notes offered by this pricing supplement have been executed and
        issued by TD and authenticated by the trustee pursuant to the indenture and delivered, paid for and sold as contemplated herein, the Notes will be valid and binding obligations of TD, enforceable against TD in accordance with their terms, subject
        to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, receivership or other laws relating to or affecting creditors&#8217; rights generally, and to general principles of equity (regardless of whether enforcement is
        sought in a proceeding at law or in equity). This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by Canadian law, Fried, Frank, Harris, Shriver &amp;
        Jacobson LLP has assumed, without independent inquiry or investigation, the validity of the matters opined on by McCarthy T&#233;trault LLP, Canadian legal counsel for TD, in its opinion expressed below. In addition, this opinion is subject to customary
        assumptions about the trustee&#8217;s authorization, execution and delivery of the indenture and, with respect to the Notes, authentication of the Notes and the genuineness of signatures and certain factual matters, all as stated in the opinion of Fried,
        Frank, Harris, Shriver &amp; Jacobson LLP filed as Exhibit 5.3 to the registration statement on Form F-3 filed by TD on December 20, 2024.</div>
      <div style="text-align: justify; font-size: 10pt;">In the opinion of McCarthy T&#233;trault LLP, the issue and sale of the Notes has been duly authorized by all necessary corporate action on the part of TD, and when this pricing supplement has been
        attached to, and duly notated on, the master note that represents the Notes, the Notes will have been validly executed and issued and, to the extent validity of the Notes is a matter governed by the laws of the Province of Ontario, or the laws of
        Canada applicable therein, will be valid obligations of TD, subject to the following limitations: (i) the enforceability of the indenture is subject to bankruptcy, insolvency, reorganization, arrangement, winding up, moratorium and other similar
        laws of general application limiting the enforcement of creditors&#8217; rights generally; (ii) the enforceability of the indenture is subject to general equitable principles, including the fact that the availability of equitable remedies, such as
        injunctive relief and specific performance, is in the discretion of a court; (iii) courts in Canada are precluded from giving a judgment in any currency other than the lawful money of Canada; and (iv) the enforceability of the indenture will be
        subject to the limitations contained in the Limitations Act, 2002 (Ontario), and such counsel expresses no opinion as to whether a court may find any provision of the indenture to be unenforceable as an attempt to vary or exclude a limitation
        period under that Act. This opinion is given as of the date hereof and is limited to the laws of the Province of Ontario and the federal laws of Canada applicable thereto. In addition, this opinion is subject to: (i) the assumption that the senior
        indenture has been duly authorized, executed and delivered by, and constitutes a valid and legally binding obligation of, the trustee, enforceable against the trustee in accordance with its terms; and (ii) customary assumptions about the
        genuineness of signatures and certain factual matters all as stated in the letter of such counsel dated December 20, 2024, which has been filed as Exhibit 5.2 to the registration statement on Form F-3 filed by TD on December 20, 2024.</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">P-22</font> </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exfilingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Nov 24 03:45:51 UTC 2025 -->
<!--?xml version="1.0" encoding="ASCII"?-->
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 04 23:02:01 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title> </title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc. Document created using Broadridge PROfile 25.1.1.5279 Copyright 1995 - 2025 Broadridge -->



<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font-family: Arial; font-size: 9pt; text-align: left; color: rgb(0, 0, 0);"><div>
    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-bottom: 20px;">

      <div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;">Calculation of Filing Fee Tables</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="ffd:FormTp" id="ixv-32">F-3</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-33">TORONTO DOMINION BANK</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 12pt; font-weight: bold;">Narrative Disclosure</div>
        <div style="text-align: center; font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>

        <ix:nonNumeric contextRef="c0" escape="true" name="ffd:NrrtvDsclsr" id="ixv-26"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is <span style="text-decoration-thickness: initial; float: none; display: inline !important;">$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:NrrtvMaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-34">18,949,000.00</ix:nonFraction></span>. The prospectus is a <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ffd:FnlPrspctsFlg" id="ixv-35">final prospectus</ix:nonNumeric> for the related offering.</div></ix:nonNumeric><div><br/>
        </div>
      </div>
    </div>
  </div></div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="ffd:CombinedProspectusTableNa" id="ixv-38">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-39">0000947263</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:FeeExhibitTp" id="ixv-40">EX-FILING FEES</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OfferingTableNa" id="ixv-41">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OffsetTableNa" id="ixv-42">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:RegnFileNb" id="ixv-43">333-283969</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:SubmissnTp" id="ixv-44">424B2</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000947263</xbrli:identifier>
  </xbrli:entity>
<!-- [WMV6][wEayVPISkz4rDKVTbCGEZRNdoJ2CEmAAwyrbcduVfDysTPa2YGUZiIio87eJ0Ud8HtesXtAVKqd2xTACp74uerQuG0CIDIosCcklf0K27YmOIbODLFxEaxvmK0lcjaiLEL0VKB0bYkRtsVV+Og2Iad1L+CqTLHeI3t9iFlJis7Xe5ATOZ7HoBEstPdPMgOuGwEIbjbcYdMmrsxLpgoIrZFXUcpJsENYS5849wxZRtJhDDhb8B0C0rHKNKEDaFnys7NSh+0IEHTFHohjtS25fumVG45t0aRzguZQTbGd+CoxE5FP3U37Y8sXNn8iQALH455GS5XJ6TmITk6H/1Ga8s9pRrMrleyLJF86wKFpO2tynYCdAYjbXgbNa0LE4jBlEVVQfYGp5clUE13wmwp40X7/ZtPbg9ujcjdD9dK//79SoReftgVCpxzznVuuF8eivW+7yKQ==] CSR-->
  <xbrli:period>
    <xbrli:startDate>2025-11-21</xbrli:startDate>
    <xbrli:endDate>2025-11-21</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>
</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image00003.jpg
<TEXT>
begin 644 image00003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  S #L# 2(  A$! Q$!_\0
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M^(K,:_C^S"6\[)8#[IQ]WGKCI7IWV?X5?WHO^_MS_C7R]+#^U5^9+U9^:87
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LKV/AC2+"U2VM+3RX4SM7S7.,G)Y)SU-%%.-&G'517W%0P>'IN\*<5Z)'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image00004.jpg
<TEXT>
begin 644 image00004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" %) A4# 2(  A$! Q$!_\0
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M[\+_ (4?V/IG_0.LO^_"_P"% ' ZI\*?#=_=13QZKJ]B?LL-G=+8W_DB]CB
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M@LIXX9D58XX<!/+&TX/ SG-=G_8^F?\ 0.LO^_"_X4?V/IG_ $#K+_OPO^%
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MA5;^Q],_Z!UE_P!^%_PH_L?3/^@=9?\ ?A?\* +/VF#_ )[1_P#?0H^TP?\
M/:/_ +Z%5O['TS_H'67_ 'X7_"C^Q],_Z!UE_P!^%_PH L_:8/\ GM'_ -]"
MC[3!_P ]H_\ OH56_L?3/^@=9?\ ?A?\*/['TS_H'67_ 'X7_"@"S]I@_P">
MT?\ WT*/M,'_ #VC_P"^A57^Q],_Z!UE_P!^%_PK#O+G2%O#9:7HUMJ5ZK%9
M4@BC"0XVY\QSPIPX.WJ1T% '3?:(3TEC/_ A4M<G9^$8)KBWNM<2RN9X662.
M&WM5A@BD&?F Y9NO\1(R,@"NL'2@ HHHH **** "BN9\5>*1H-S;6J:?+>7%
MP"8P+B&!.,DC=(ZY. 3@ UI^'-777-*AOX[::WCE&564HVX=F!1F4J>Q!H T
MZ*** "BC-&: "BC-% &9I_\ R&=6_P!Z+_T"M.LS3_\ D,ZM_O1?^@5IT %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4455U&_MM.M)+F\F6*&-6<D\D@ DX Y)P#P.: +59>L:W:Z6RQOOGO)%9H;
M2 !IIMHR0J_3UQ5$3ZSJ[;K!1I=C_P ]+J'=/(=PY5-V%4KW;Y@?X:T-)T:S
MTH.;:-FGDQYMQ*Q>67' +N>30!G&PU75VSJTIT^S'2TLYMS2<G/F28'!7'RJ
M!CGYCQ6Y96L-E;1V]M&(X8U"*H[ # Y[\ =:GHH **** "BBB@ HHHH \[^,
M5O$=.TRZ:VTR1X[K8TUVMMO1"C9$9G^3).,CTS78>&&5_#VFLA4J;=""FS&,
M#IY?R8_W>/2N;^+5S]G\/VXWR0B2X"&82^5'&-K',C>6^ >@^7J16[X*2&/P
MEHR6MM-:P"TC"03G+QC:.&/<T ;=<KXB\7)H-SJ?]H6OEV=G9I<I.90/.9FV
MA /X><#)]?05U55VL[=[IKEHE,[1^27/4IG./SH Y/POXPFURZT]OL=NEA>Q
M )+'.799A$LC+C&"H!(# ]1TJG-XWU)9)(X=+M&=HVO(-UPP#6J[MQ;Y/ED^
M7A>1SUXKJ+?PSH]M=_:;>Q2.?[.+4,K,,1@ 8 S@< #(YXZU6?P7X>D29'TR
M,K-,)WR[<N,^_3D_+T.3QS0!B:EXQU6-I_[+T6.^5E/V1!/MD<IL\S>",  /
MQ@GIVKI?#FMP:W9R30/ 61RK1QRAVC]-^/NDCG'H:=_PCNE?;KR\^QI]INX_
M)F<$_,F ,8S@< 9QC.!4NFZ-I^F37<MA:I!)=N))BN?G8# ^GT'% &=9ZOIL
M>L:H9+^T4,T>"9E&<+SWK0_MS2O^@G9?]_U_QJ/3U']LZKD#[T7;_8K4VK_=
M'Y4 9_\ ;FE?]!*R_P"_Z_XT?VYI7_02LO\ O^O^-:&U?[H_*C:O]T?E0!G_
M -N:5_T$K+_O^O\ C1_;FE?]!*R_[_K_ (UH;5_NC\J-J_W1^5 &?_;FE?\
M02LO^_Z_XT?VYI7_ $$K+_O^O^-:&U?[H_*C:O\ ='Y4 9_]N:5_T$K+_O\
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M:3IY2243NIMDPT@Z.>.6'KUH X[4/%7B!Y[F/1H-,DD9&,$%QE7AV;"[2-N
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MOS_^ TO_ ,36I10!E_V]8?WY_P#P&E_^)H_MZP_OS_\ @-+_ /$UJ44 9?\
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MMZP_OS_^ TO_ ,36I10!E_V]8?WY_P#P&E_^)H_MZP_OS_\ @-+_ /$UJ44
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M[/4I;2*.1FEM88]B3(1@*V#@\[F)(.<]NM=4.E %3RKK_G[7_OT/\:/*NO\
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M +?T[_GK+_WXD_\ B:/[?T[_ )ZR_P#?B3_XFM2B@#+_ +?T[_GK+_WXD_\
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M:0?]-G'7_<7CU)K:T]$A>YBB54B1U5$48"C8O ':@"O_ &_IW_/67_OQ)_\
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M7_GPU+_P&:C^VE_Y\-2_\!FK5HH RO[:7_GPU+_P&:C^VE_Y\-2_\!FK5HH
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M:<*9I.2&55!(3(P0Y)/^S6AH^C6>DPE+1"7<[I9I&WR2M@ LS'DDX&:T<44
M &**** "JMI_Q\WG_70?^@+5JJMH<W-Y_P!=0.O^PM %JBBB@ HHHH JQ_\
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M+S&/,B$-O[1H7Z_[1RWTZ5N_;[S_ * ]U_W]B_\ BZ74]8LM.GA@N)&-S/\
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MI_X&'_XW65JWB.]L)H[5--@N]1EYCM(+LM(1_>/R85?]IB!3CJE]KW[O0/\
M1[ \-J<J9W_]<4/WO]\_+Z;JF TGPI:G&XW%PQ/),EQ=R;2<<\LQVG _ 8H
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M?^!A_P#C='VC5O\ H'VG_@8?_C=:5% &<EQJA=0]A:JF>2+LD@?396B.E%%
M!1110 4444 <'\4[R6.SL[>TFN(K@R[Q$L+21W(*.#&P5U8@#YN/09X-='X-
MV?\ "*Z1Y=S)=(+2,">10&D&T<D G!_$UQGQRL()]"L+P1:,;R"Z58WU&-26
M4@[D0E6P2.O'0'O7;>$\_P#"-:7N-J3]FC_X]4V0]/X!@87TX% &M111F@ H
MHS10 449HH S-/\ ^0SJW^]%_P"@5IUF:?\ \AG5O]Z+_P! K3H **** "BB
MB@ HIK,%4LQ"J!DDG  KG'U>[UIVA\-[5M@<2:I*N8Q_UR7_ ):'W^Z/4]*
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M[@+D=<-Z#BO7L"C% 'E]IX,N+RPUFSU>QN%2:%1/+#.@;4)UD+B4<G'&%^8
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M6K=:?9W;A[NTMYV48!DC5B!Z<BIXHTB14C1411A548 'H!0 ^BBB@ HHS10
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M?^N*?S:K558_^0E+_P!<4[>[5:H **** "BBB@ HHHH **** "BBB@ HHHH
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M?*3QA\IR3F@#TEM)TYK,6C6%H;58_)$)A78$R#MVXQC@<=.!5Q55%"H J@8
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M6;'4^YJ>BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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=10 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image00005.jpg
<TEXT>
begin 644 image00005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" &! CD# 2(  A$! Q$!_\0
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MZ84G/-2:GJ=AI<22:G>VUG&S;5>XE6,$XZ9)ZXH NT5G-K6EK>0VCZE9+=3
M-%"9U#R ]"HSD@]J='JVG2:BVGQW]HU^G+6RS*91QGE<YZ'- %^N5\&_\C%X
M[_[#4?\ Z;K.NJKE?!O_ ",7CO\ [#4?_INLZ .JHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "N1\7NK^(O! 5@2NM2 X['^S[RNNKR>WN"WC'2+=D8%?%%
MQ,&/1@UC?+Q]/+-5&+:<NQ$IVDH]SUBBBBI+"BBB@ KD/&%Q$]TFFR6-WY4Z
MH]S>0V$L_P"[1]PC4HC?,3GK@*"3UXKKZ* .,U,36GB-Y=&GU4WES<0&XMFL
M_P#160!58F4QX!"9/#_>&,$\5-=:A%_;.FZR(+J[TJ6QDCBD@M9)2&9D8915
M+ ,J]<8X[9&>JD19$9)%#*PP5(R"*(T6- J *H&  , 4 >5Z'87MGX9O=&N]
M+O%U&[O$GML0,T<<>4*;I0-B^6%Q@D'Y>,Y%;-C%<,NF:<]C=C4+;5)+J:9H
M'6,+OD8N)<;6W!@, Y.2"!@X[ZB@"IJ-M+=V,L%O>W%C(XP+BW5&D3GJ-ZLO
MMRIZUYSX3\.:G)KOC-4\9^((FCU:-79(;$F4_8;0[FS;$9P0ORX&%'&<D^HU
MRO@W_D8O'?\ V&H__3=9T '_  B^K_\ 0]^)/^_&G_\ R+1_PB^K_P#0]^)/
M^_&G_P#R+7544 <K_P (OJ__ $/?B3_OQI__ ,BT?\(OJ_\ T/?B3_OQI_\
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M^_&G_P#R+7544 <K_P (OJ__ $/?B3_OQI__ ,BT?\(OJ_\ T/?B3_OQI_\
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M^_&G_P#R+7544 <K_P (OJ__ $/?B3_OQI__ ,BT?\(OJ_\ T/?B3_OQI_\
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M^_&G_P#R+7544 <I_P (OJ__ $/?B3_OQI__ ,BT?\(OJ_\ T/?B3_OQI_\
M\BUU=17$\=O!)-,P2*-2[L>@ Y)H \W\7QZOX>MX3%XN\07MQ,6VPRP600JH
MRY;9;JV /0@UG-IMUIGC#X>-=7MU-+?WL\\T,R(HC865R0!A=W660G<3RQ[
M =W/;6VNZI.&<2VT=GY<;QD$ RE@Y!YYPBX^I]:SO&, _P"$T\!7+*K*FH7$
M(Y(*LUE.P/OPC#\16_,E#DMZ_H<ZBY3Y_N_4[2BBBL#H"BBB@ HHHH ****
M"BBB@ KE?!O_ ",7CO\ [#4?_INLZZJN5\&_\C%X[_[#4?\ Z;K.@#JJ***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **9'(KH'1@589##H13;>:.X@CFA8/%(H=&'0@C(H
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M;SQL>OASPS_X/9__ )#KK** N<F;SQL>OASPS_X/9_\ Y#H-YXV/7PYX9_\
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M^'/#/_@]G_\ D.@WGC8]?#GAG_P>S_\ R'7644!<Y,WGC8]?#GAG_P 'L_\
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M1H5]/+(TTD\^JRQ'<P7<%Q;,2N5')VDD=. 3I>&+0P^)+RW$SF#38/)CB;D
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MPW_X-(/_ (JC_A8_@C_H<O#?_@T@_P#BJZJB@#E?^%C^"/\ H<O#?_@T@_\
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M:A-=^*=!M\B*&,2:C"N]%!;<,MR,R,/^ UM:GX;M[O\ LGR9'@7374QJ.0R
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M*,<DDD_7-245)84444 %%%% !1110 4444 %%%% !7*^,O\ D8O O_8:D_\
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MMIP1SD$?0@4:9IT&G+<"W#?Z1,\\A)R2['G^@_"L+_A ])_Y_/$G_A1ZA_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME_R,7@7_ +#4G_IOO*ZJN5\9?\C%X%_[#4G_ *;[R@#JJ*** "BBB@ HHHH
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MD_\ 3?>5U5<KXR_Y&+P+_P!AJ3_TWWE '54444 %%%% !1110 4444 %%%%
M!7*^#?\ D8O'?_8:C_\ 3=9UU5<KX-_Y&+QW_P!AJ/\ ]-UG0!U5%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1?F ARIRIX;!P0<8() /4**Y7_A/-(_Y\_$G_A.:C_\ &*/^$\TC_GS\2?\
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M_%^M7HTW2;V]:-I1;0M*47@MM!.*S[#5KM-0BL]7@@C-R-UK<6TA>*7 R4Y
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M:Z6SE.GI&UT1MC$N=H).,GH<#K@<G&*Y25;\:D_G:A:)JUC(L4$[IY<=W%,
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MCD=VZ_-[FH-%TN2.:\NK^VM89+F99A;PMYB(X7&_)4?.>Y '0>];M !1110
M5%-+'!"\LSI'&@+,[G 4#N3Z52UW5[;0]/:]OO.\A656,49<C)P.G;)ZUQE[
MX@BU&ZDT674+;S9YXYK"2:,QG<L@=8)HFPPY7 ;'S#C[PP0#1NO&5I<7UG%8
M7T4<5Q)):[W3<"[<1RH?NNH8;2 3]\9QBMW^P[22ZL+JY\VYN+*,I&\KELDX
M^8CH6XX/;/%5]%TJ5;N^O-1MK2%[F2.3[/"WF(KH/];N*CYSQVZ**WZ "BBB
M@ IDCK'&SR,JHHW,S'  ]35+6]4M]&TV6_O?,$$6-Y1"Y )QG [<]:XW4O$5
MOJ$L^D7&H0(MZZM:23QF)HY P8131-AMI(P&QR"5/."P!>OO&MB]U:BQO81"
M\YMG9P&1]WRK)&P.UPK;<@'.TDG&*VVT"TFGTZ>]::[N+%6"/*^=Q8J2S <'
ME%([# P.!B#2-*G;4+V^U2VLX7N!$I@A8RH6CW?O22J_,<@#CHHY[#H* "BB
MB@ IDC+&I9R%51DDG&*IZUJ4&CZ9/?WGF?9X!N?RT+$#(&<#]?;-<7JWB2UO
MGN=+N-0B2WU  6SS1&)[=^,)+&P!9"<?-TY*GL2 :.H>-=/^T6QLK^#R1<>3
M(S#<DH88#1N#M;:Q4D YV[L@5LRZ!:W3:>^H-+>2V99E>5N'9B"2P'!&0"!T
M&!@<"J^DZ5</J-W>ZK:V,+3QQQM# QD61D)/F$E1SR !C( Z]AT- !1110 4
MC,%4EC@#J35/5]0ATK3;B^NO,-O N]_+0NV!UX'Z^@KB-5\3VEXUUIUSJ,<=
MAJ4>R"22,Q2VS$8 >-@"T;'^+&.<'@@T :&J^-].BDB:SOH?(CN1',Y&Z.5"
M,$QN#M)4D,5!SA6X[UMR:!;W,=A_:,DM[+:.TH>5N'<\Y91QC/(7H,#TJKI>
ME74NHW%YJ]K81&2!('AMV,B3%6)#MN4=.@'./6NCH **** "D)P,GBJFJ7\6
MF:?<7ER)##;H9'V(7.!Z 5Q.K>*K&Z^TV-UJ"1:=JD/EQ22QF&6U9EQ\RM@O
M&2<[AP">>"" "_JWC?3H&5[2]A:*WN%69N&CEC(^;9(/EW+N#%<YPI&.<UKR
M:!;7L-D-4EEOI+:4S;Y#A78YX*CC;Z+TX'7O6TS2;J74GN]6M+"+=;"UDBMV
M+I/@Y#,&48 Z*.<;CS72T %%%% !15:_NH[&QGNIE<Q0H9&$:%VP!G@#J:XC
M4_%]A.LB3:AY>E:C!Y09T,,UL67'F , 7C.0=PSCKDKR "_KGC73K42-9WD3
M?995,Q&&CE3^-%<<!P,D+D,2N,<UJS:%;:G96R:G-)?JL_VH,6VJQ*L ,#C9
MAB-O0CKG)S2T?1[J2^BN-3MM-1([0VA^RDLMRI*D$J5 4 +POS8W$9QUZ@#
MP. *  # P. *6BB@ HJ"\N%M+2:XD#LD2,[!%+,0!G@#DGVKA=0\:V,C!VOM
MND7T'ED21F&>W+#_ %B[@/,3!YVYQUY&< &AX@\:6%HD_P!AO(7DM)$:4C#Q
MR*#\\8<<+)C. <$D #-:<FBVNK:;"NH7$E_$TWVH-OVJ^5("@#^#:<8[CKG)
MS1T71[I[NSFU"+3A#;6C6H>U)87<9VXRI&%4;<XRW)."!UZI5"*%4  #  [4
M "J$4*H  & !VIU%% !1110 4444 %%%% %74+.#4+.6UO(EF@E7:Z,.#_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
'!1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Nov. 21, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000947263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">TORONTO DOMINION BANK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-283969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Nov. 21, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvDsclsr', window );">Narrative Disclosure</a></td>
<td class="text"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is <span style="text-decoration-thickness: initial; float: none; display: inline !important;">$18,949,000.00</span>. The prospectus is a final prospectus for the related offering.</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 18,949,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvDsclsr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvDsclsr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>12</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exfilingfees.htm">exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 12,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/ffd/2025": 6,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 107,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 10,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001140361-25-043261-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-043261-xbrl.zip
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MB/&-BR^E.7#*<],C[D9'#0H&?43)&B-?L(YJ(?^(A!+9=,G"UY&+Y[!B!VY
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M              "  0    !E>&9I;&EN9V9E97,N:'1M4$L%!@     !  $
*/@   ( (      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000947263</identifier>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <ffd:FormTp contextRef="c0" id="ixv-32">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-33">TORONTO DOMINION BANK</dei:EntityRegistrantName>
    <ffd:NrrtvDsclsr contextRef="c0" id="ixv-26">&lt;div style="text-align: center; font-family: Arial; font-size: 12pt;"&gt;The maximum aggregate offering price of the securities to which the prospectus relates is &lt;span style="text-decoration-thickness: initial; float: none; display: inline !important;"&gt;$18,949,000.00&lt;/span&gt;. The prospectus is a final prospectus for the related offering.&lt;/div&gt;</ffd:NrrtvDsclsr>
    <ffd:NrrtvMaxAggtOfferingPric contextRef="c0" decimals="2" id="ixv-34" unitRef="usd">18949000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c0" id="ixv-35">true</ffd:FnlPrspctsFlg>
    <ffd:CombinedProspectusTableNa contextRef="c0" id="ixv-38">N/A</ffd:CombinedProspectusTableNa>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-39">0000947263</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="c0" id="ixv-40">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:OfferingTableNa contextRef="c0" id="ixv-41">N/A</ffd:OfferingTableNa>
    <ffd:OffsetTableNa contextRef="c0" id="ixv-42">N/A</ffd:OffsetTableNa>
    <ffd:RegnFileNb contextRef="c0" id="ixv-43">333-283969</ffd:RegnFileNb>
    <ffd:SubmissnTp contextRef="c0" id="ixv-44">424B2</ffd:SubmissnTp>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
